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The mechanisms by which cholera toxin causes its
characteristic diarrhoea were studied in rabbit intestinal
epithelial cells, in contrast to most of the previous work
on the toxin which was carried out on cell types not
involved with the pathology of the disease. Brush border
and basal-lateral membranes were prepared from intestinal
epithelial cells by differential centrifugation and MgCl2
precipitation. The purity of the membrane fractions was
assessed by marker enzyme analysis; sucrase activity was
18.4-fold greater in brush border than in basal-lateral
membranes, whereas {Na+-K+)ATPase activity was only 2.8-fold
greater in basal-lateral than in brush border membranes.
The lower enrichment factor for (Na+-K+ )ATPase is due to the
heterogeneous distribution of basal-lateral membranes which
occurs when the technique of MgCl2 precipitation is used.
The active Ai peptide of cholera toxin catalyzed the
transfer of the 32P-ADP-ribose moiety of [adenylate-32P]NAD+
to three proteins of molecular mass 45, 40 and 37 kDa in
brush border membranes only. This ADP-ribosylation caused a
20% release of the 45 and 40 kDa proteins from the membranes
after an incubation time of 20 min. The 40 kDa protein has
the same molecular mass as the oc subunit of the stimulatory
regulatory component (Gsot ) of adenylate cyclase. Both
cholera toxin and sodium fluoride activated the catalytic
component of adenylate cyclase in basal-lateral membranes
only, but by first modifying the same regulatory component
in brush border membranes. Thus, in the intact cell, Gs<* is
released from the brush border membrane into the cell
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cytosol upon ADP-ribosylation by cholera toxin and moves to
the other side of the cell, i.e. the basal-lateral membrane,
where it activates adenylate cyclase. The resulting
elevation in the cyclic AMP content of the cell (induced by
cholera toxin) activated cyclic-AMP-dependent protein
kinases which increased the phosphorylation of two proteins
of 53 and 42 kDa, and caused the unique phosphorylation of a
36 kDa protein and possibly two of 45 and 30 kDa, all in the
brush border membrane. These changes in the phosphorylation
of proteins in the presence of cholera toxin are thought to
be responsible for controlling the decrease in Na+-Cl-
absorption in villus cells and increase in CI- secretion in
crypt cells, resulting in a massive water loss. The effects
of six antipsychotic drugs (phenothiazines) on the ADP-
ribosylation of Gs<* and the activation of adenylate cyclase
was investigated. A correlation was found between the
effects of antidiarrhoeal drugs on the ADP-ribosylation of
Gs« and the activation of adenylate cyclase with their
reported antidiarrhoeal activities and abilities to bind
calmodulin: the greater the drugs' affinity for calmodulin
and ability to inhibit the diarrhoea, the greater was the
inhibition of ADP-ribosylation and adenylate cyclase. Since
calmodulin is involved in the activation of many different
enzymes and the drugs bind calmodulin with varying
affinities, it is possible that the drugs inhibit the
diarrhoea by binding to calmodulin and so inhibiting ADP-





1.1 Cholera the disease
Cholera is a disease that has plagued the world throughout
history, assuming pandemic (meaning spread rapidly over a
wide geographical area) proportions on seven occasions since
1817 (Garfield, 1986). It is a massive diarrhoea resulting
from an enormous secretion of fluid (over a litre per hour)
into the small intestine, leading to dehydration, kidney
failure, circulatory collapse and ultimately death in about
50% of cases if left untreated. Although it is not the most
prevalent of the diarrhoeal diseases it certainly causes the
most severe fluid loss, and is therefore responsible for a
large proportion of life-threatening illness and death
during the cholera season in endemic areas. It is estimated
that each year there are approximately 1,000 million cases
of acute diarrhoea in children under 5 years of age in Asia,
Africa and Latin America, resulting in 5 million deaths
(Holmgren, 1981).
Despite all the major advances that we have seen in medicine
and public health, the increase in volume of international
traffic has provided a good means for spreading cholera
beyond the endemic areas.
1.1.1 History
The first recorded cholera pandemic began in 1817 in Jessore
(now Bangladesh), India (Longmate, 1966). The term 'Asiatic
Cholera' was used to distinguish this disease from other
similar illnesses. This Asiatic Cholera swept through
India, across the Arabian Sea to the Middle East and into
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Russia. In 1832 almost every European capital had been
affected. This type of worldwide cholera epidemic would
recur six more times.
The current, seventh pandemic began back in 1961 in
Indonesia, from where it spread to Southeast Asia, the
mainland of Asia and through the Middle East, reaching
Africa in 1970. By 1973 cholera was endemic in Malawi,
Mozambique and Angola. The disease is now apparently
endemic along the United States Gulf Coast.
The cause of the disease is the comma-shaped gram-negative
bacterium Vibrio cholerae which was first identified and
isolated by Pacini in 1854, and later reaffirmed by Robert
Koch in 1883. Koch suggested that the characteristic
diarrhoea of cholera was due to a poison produced by the
bacteria in the small intestine. His reason for believing
this was that the invading bacteria were only found in the
contents of the patient's intestine and not in the
surrounding tissues or the epithelial wall. However, this
idea of cholera being a toxicosis was not substantiated
because intraperitoneal injections of the culture filtrate
of V. cholerae failed to produce symptoms of the disease in
experimental animals.
It was this difficulty in finding suitable animal models
that was apparently the main reason for the long lapse in
studies on the pathogenesis of cholera. Oral administration
of even large amounts of live V. cholerae either failed to
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induce the infection or killed the animal through
septicaemia rather than diarrhoea. Also the findings that
the intestinal epithelium of cholera victims was desquamated
and sloughed further led to the misconception of the
aetiology of cholera. Thus, the disease state of cholera
was generally thought to arise from denudation of the
intestinal surface by the invading bacteria, possibly
through the action of digestive enzymes and mucinase (Burnet
and Stone, 1947), resulting in the exudation and loss of
body fluid. This view prevailed through the first half of
the 20th century although great physicians of the mid-19th
century had noted, even before the discovery of V. cholerae,
that the characteristic rice-water stool in cholera
consisted of water and "blood salts" but contained very
little albuminous matter, suggesting a role of poison rather
than physical lesion in the disease (Finkelstein, 1973).
It was not until the great Egyptian epidemic in 1947 and the
Thai epidemic in 1958 that better observations and
procedures were made on the composition and dynamics of
electrolytes and fluid movements. This was to form the
basis of fluid replacement therapy which was to save many
millions of lives from cholera (see section 1.1.3). The
rapid recovery of patients seemed to indicate again that
poisoning was the cause of the illness. In the late 1950's
there was to be a resurgence of interest in cholera due to
these observations.
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In 1953 De and Chatterje developed the first successful
animal model for cholera. They managed to collect "rice-
water" which had accumulated in ligated segments of the
small intestine of rabbits after they had been injected with
a live vibrio suspension.
In 1959 De and Dutta et al. demonstrated that the bacterium
secretes enterotoxin, a diarrhoea-causing agent, by
producing experimental cholera in the animal model with a
cell-free culture filtrate of V. cholerae. By this time the
technique for biopsy of the small intestine was available
and in 1960 Gangarosa et al. reported that the small
intestine of cholera patients showed no evidence of damage
during profuse diarrhoea. Thus, the desquamation of the
intestine observed earlier was now known to be due to a
post-mortem artefact and not due to the disease.
The toxin was first isolated in 1968 by Richardson and Evans
and then by Finkelstein and LoSpalluto (who called it
choleragen) in 1969. The toxin was found to consist of
several subunits. During the final step of the purification
procedure a protein which cross-reacted with anti-cholera
toxin antibody but was not enterotoxic was separated from
the enterotoxin and was named choleragenoid. Choleragen and
choleragenoid were obtained in crystalline form in 1972
(Finkelstein and LoSpalluto).
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Field (1971), using the purified material, showed that
cholera toxin greatly stimulated the flow of electrolytes,
particularly Na+ and Cl~, across the ileal mucosa, from the
serosa to the lumen. This event was mimicked by cyclic AMP
or substances such as theophylline that increased the cyclic
AMP content of tissues (reviewed by Field, 1980). It was
proposed that cholera toxin elevated the cyclic AMP level in
enterocytes and then some cyclic-AMP-dependent biochemical
process changed the flow of electrolytes through the
intestinal epithelium. This hypothesis was soon supported
by the observation that the cyclic AMP content in the mucosa
was increased by placing cholera toxin in the intestinal
lumen (Schafer et al., 1970), Cholera toxin was later shown
to activate adenylate cyclase in the small intestine without
affecting the cyclic nucleotide phosphodiesterase activity
(Kimberg et al., 1971; Sharp and Hynie, 1971), in other
words the activation of the cyclase was not due to
inhibition of the breakdown of cyclic AMP. Furthermore,
cholera toxin could induce lipolysis in fat cells, which was
mediated by cyclic AMP (Vaughan et al., 1970). This and
other observations suggested that the activation of
adenylate cyclase was the primary action of cholera toxin
not only in the intestine but also in other cells and
tissues. It is now clear that cholera toxin can activate
adenylate cyclase in almost all vertebrate cells.
Two strains of V. cholerae have been identified, the common
form, which is the one that was discovered by Pacini, and
the classical form, which was isolated in 1905 and is called
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V. cholerae el tor. The common form is thought to have been
the major cause of epidemic cholera for the first six
pandemics whereas V. cholerae el tor is the primary cause of
the present seventh pandemic, virtually replacing
V. cholerae as the main epidemic strain. However, it has
been noted by the International Centre for Diarrhoeal
Disease Research in Dacca, Bangladesh that as recently as
1982 V. cholerae is again gaining advantage as the major
cause of cholera (Samadi et al., 1983). V. cholerae el tor
can survive much better in the environment than V. cholerae
and causes a broader range of disease (Mackay, 1980).
V". cholerae immobilizes patients reducing their capacity for
spreading the disease while V. cholerae el tor produces
moderate cases allowing victims to move around with only
mild discomfort. This means that these victims act as
dangerous vectors of the disease.
1.1.2 Transmission
The mode of transmission of cholera has been the subject of
debate since the early 1800's. In 1849 it was discovered by
John Snow that cholera is a waterborne infection and he
suggested that it is a contagious disease caused by a poison
reproducing itself in the bodies of its victims and
spreading through excretions and vomit that then contaminate
the water supply. Cholera can be transmitted by eating
contaminated food as well as by drinking contaminated water.
In 1978 a cholera outbreak along the Gulf Coast of Louisiana
turned out to be due to cooked crabs from the Louisiana
marshes (Blake et al., 1980).
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Thus, V. cholerae is spread by food and water which have
been contaminated by human excrement. The bacteria thrive
in the human digestive tract where they multiply and produce
the enterotoxin. This toxin binds to the intestinal lining,
triggering the hypersecretion of fluids into the lumen of
the intestine leading to the characteristic watery diarrhoea
of this disease. As much as 25% of the body's fluids are
drained within hours as well as depleted of essential salts.
The result is that the patient faces dehydration and
metabolic acidosis, leading to a painful death within a few
hours unless treatment is administered (Mackay, 1980).
1.1.3 Treatment and control
Cholera patients suffer so much fluid loss that unless they
are treated quickly they die from dehydration long before
their bodies have time to mount an immune response to the
infecting bacteria. The treatment is very simple,
consisting of the replacement of lost fluids and the
infusion of salts to restore the body's water and chemical
balance. This is almost always effective but 58% of victims
die if they do not receive prompt medical attention.
In Third World countries, where cholera is most prevalent,
any kind of treatment must be simple, inexpensive and
available to large numbers of patients. The easiest method
is that of oral rehydration therapy in which essential
fluids and salts that are lost during the severe diarrhoea
and vomiting are replaced. This type of therapy can reduce
the mortality to less than 1%.
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As far as antibiotics are concerned there has not been much
success in the treatment of cholera. However, if used in
conjunction with oral rehydration, drugs reduce the volume
of fluid loss and hence the amount of replacement fluid
necessary.
Epidemiological observations have also indicated the
development of an acquired immunity by infected individuals.
In fact, in endemic areas the incidence of cholera infection
has been found to be higher in children under 4 years of
age, while it is diminished in older people. This has been
found to be due to an increase in the cholera antibody with
age (Mosley et aI., 1968).
Although a century of research has passed, there has not
been a satisfactory vaccine developed. At first, research
involved trying to develop a vaccine that would stimulate
the immune system to fight the invading bacteria. However,
antibacterial cholera vaccines have an efficiency of only
40-80% for a short duration of 3-6 months (Feeley and
Gangarosa, 1980). Since De's discovery of the enterotoxin,
research has been redirected to find a vaccine that will
spark the immune system in the gut to fight the toxin rather
than the bacteria.
Another approach to vaccination has been to construct a
weakened or attenuated strain by recombinant DNA techniques
(Kaper et al., 1984). The genes encoding toxin production
are removed, and the genes encoding the antigens likely to
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be involved in immunity are preserved. This strain can then
be administered as an oral vaccine, stimulating antibody
production to protect the body from future bacterial
invasion while not producing the severe symptoms associated
with the disease.
As well as using vaccines and drugs though, health education
is a major factor in lowering the incidence of cholera.
Azurin and Alvero (1974) of the joint Phi1ippines/Japan/WHO
Cholera El Tor Research Project, found that sanitation
measures in conjunction with an uncontaminated water supply
reduced the number of cholera cases by 76%.
1.2 Structure and function of cholera toxin
1.2.1 Structure of cholera toxin
Cholera toxin has been shown, by sedimentation equilibrium
ultracentrifugation, to have a molecular mass of
approximately 82-86 kDa (LoSpalluto and Finkelstein, 1972;
Sattler et al., 1975; van Heyningen, 1976; Lai et al.,
1976). This protein, which can be easily purified from
culture filtrates of V. cholerae (Finkelstein and
LoSpalluto, 1969), contains no detectable amounts of
carbohydrate or lipid (LoSpalluto and Finkelstein, 1972).
Crystals of the toxin have also been obtained (Finkelstein
and LoSpalluto, 1972). The molecule has been found to be
very stable in that it can refold to an active configuration
after being treated with SDS or 6M guanidinium chloride.
Analysis by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) has shown the toxin to consist of two types of
subunits, called A and B, which are non-covalently
associated (Finkelstein et al . , 1972; Cuatrecasas et al.,
1973; van Heyningen, 1974). Further studies revealed that
there is one A subunit (27-30 kDa) and several identical B
subunits (8-14 kDa) (van Heyningen, 1974; Finkelstein et
al . , 1974; Gill, 1976a; Kurosky et aI., 1977 ). The B
subunits exist as an aggregate even in the presence of SDS
due to strong non-covalent interactions between them, and
can only be separated by boiling in SDS. The bacterium
synthesizes subunit A as a single precursor polypeptide
chain which is rapidly nicked into two chains by bacterial
proteases (Gill and Rappaport, 1979; Mekalanos et al.,
1979b). These two chains, called Ai (18-25 kDa) and A2 (5-
9.7 kDa), are covalently linked by a disulphide bond. The
nicking of the A subunit does not produce an appreciable
decrease in the molecular mass, suggesting that few amino
acids, if any, are lost. The precursor polypeptide has a
NH2-terminal sequence similar to that of the Ai fragment and
the same COOH-terminal amino acid (Leu) as the A2 fragment
(Duffy et al., 1981a). Thus, the precursor has the sequence
NH2-Ai-A2-COOH.
1.2.2 Subunit arrangement
From calculations of molar ratios using the molecular masses
of each subunit and of the whole toxin, Lai (1977) proposed
that there are five B subunits for every A subunit. This
ratio has been verified by Gill (1977), van Heyningen
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(1977b) and Ribi et al. (1988). The only way of arranging
these subunits whilst maintaining a symmetrical structure is
for the B subunits to be in a ring with the A subunit on the
axis (Fig. 1-1) (Gill, 1976a; van Heyningen, 1977a; Ribi et
al., 1988). Evidence supporting this model comes from high
resolution electron microscopy which shows molecules in a
ring form (Ohtomo et al . , 1976) and from cross-linking
experiments with bifunctional reagents (Gill, 1976a). X-ray
diffraction analysis of the crystalline toxin is also
consistent with five B subunits per molecule (Sigler et al. ,
1977; Ribi et aI., 1988).
Mekalanos et al. (1979b) and Tomasi et al. (1979) have shown
that the A subunit appears to be associated with the B
subunits via the A2 fragment. They found that the structure
of the toxin was not altered by reducing the disulphide bond
between the Ai and A2 fragments and that there was no
dissociation of the Ai or A2 from the B subunits. However,
in the presence of SDS Ai was released leaving the A2-5B
complex. Thus, it seems apparent that as well as the
disulphide bond, non-covalent bonds are important in the
binding of the Ai fragment to the A2-5B complex.
1.2.3 Choleragenoid
As well as secreting the toxin the bacterium secretes an
aggregate of the five B subunits, without the A subunit,
which immunologically cross-reacts with cholera toxin but
has no toxic activity. This protein is called choleragenoid




Fig. 1-1 Proposed model for the structure of
the cholera toxin molecule.














determining its molecular weight by sedimentation
equilibrium ultracentrifugation. The molecule was found to
have a molecular mass of 54.3-58 kDa (LoSpalluto and
Finkelstein, 1972; van Heyningen, 1976) which is identical
to the molecular mass of the B subunit aggregate (Sattler et
al., 1975; Lai et al . , 1976). Further evidence was revealed
by SDS-PAGE where only the B subunit was observed in
choleragenoid (Finkelstein et al., 1972; Cuatrecasas et al.,
1973; Lonnroth and Holmgren, 1973; van Heyningen, 1974). A
mutant of V. cholerae called Texas Star, which only produces
the B subunits, has beeh isolated by Honda and Finkelstein
(1979 ) .
1.2.4 The primary structure and structural genes of the
subunits
The complete amino acid sequence of both subunits is known
(Nakashima et al., 1976; Lai, 1977; Lai et al., 1979; Duffy
et al., 1981b; Mekalanos et al. , 1983). The B subunit is
composed of 103 amino acid residues (see Appendix A), has a
molecular mass of 11,604 Da, which is consistent with the
subunit composition of ABs for the holotoxin (Lai, 1977),
and shows similarity to the B chains of glycoprotein
hormones such as thyrotropin, luteinizing hormone and
follicle stimulating hormone (Ledley et al., 1976; Kurosky
et al., 1977). The A subunit is composed of 240 amino acid
residues (see Appendix B), of which 193 (or 192) make up the
Ai peptide (Lai et al., 1979; Mekalanos et al., 1983) and 46
(or 47) make up the A2 peptide (Duffy et al., 1981b;
Mekalanos et al., 1983): the reason for this discrepancy is
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that sometimes the two peptides are cleaved between Ser 193
and Ser 194, and sometimes they are cleaved between Arg 192
and Ser 193 as well as between Ser 194 and Met 195 with the
loss of the two serine residues (see Appendix B).
The structural genes, ctxA and ctxB, of the toxin have been
cloned and their complete nucleotide sequence determined
(Pearson and Mekalanos, 1982; Mekalanos et al., 1983). The
two genes are cotranscribed from a polycistronic operon
(Mekalanos et al . , 1983) which is part of a 7-12 kilobase
genetic element (Mekalanos, 1983), with the A cistron (ctxA)
preceding the B cistron (ctxB) (Pearson and Mekalanos,
1982). The nucleotide sequence of the ctx gene suggests
that both ctxA and ctxB are cotranscribed from a single
promoter, which precedes the ctxA gene (Rosenberg and Court,
1979 ) .
Several genetic factors influence the level of cholera toxin
production. The first is the copy number of the toxin
genetic element. Amplification of this element increases
the production of the toxin (Mekalanos, 1983). Secondly,
the number of tandem repeats of the sequence TTTTGAT
upstream of the ctx promoter affects toxin expression
(Miller and Mekalanos, 1984), and thirdly, there are at
least two regulatory genes, one whose product stimulates the
transcription of ctxAB and one which may encode a negative
regulatory factor (Miller and Mekalanos, 1984).
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1.2.5 Role of each subunit
Both the A and B subunits are required for the expression of
toxicity (Finkelstein et al., 1974; Sattler et al. , 1975;
Gill, 1976a). The B subunit has been shown to bind to
ganglioside Gmi, a cell-surface glycolipid, but this binding
is not toxic to cells. Subunit A does not bind ganglioside
significantly but the Ai peptide alone can activate
adenylate cyclase in cell-free extracts. Therefore, the Ai
fragment must be transported to the cytoplasmic side of the
cell's plasma membrane where it activates adenylate cyclase
by the ADP-ribosylation of the regulatory component of
adenylate cyclase. The details of these events will be
described in the following sections.
1.3 Interaction of cholera toxin with cell membranes
1.3.1 Ganglioside Gmi as the receptor
The initial event of the action of the toxin is to bind to
the cell membrane via some specific receptor. It was
suggested by van Heyningen et al. (1971) that gangliosides
are the receptors for cholera toxin. This was deduced from
their observation that the preincubation of cholera toxin
with mixed gangliosides neutralized the toxic activity.
Subsequently, ganglioside Gmi was shown to have the
strongest inhibitory effect, being 50-100 times greater than
Gdia , Gm2 , Gm3 etc (Cuatrecasas, 1973a; King and van
Heyningen, 1973). The neutralization was explained by the
binding of the toxin to the free Gmi thus preventing it from
binding to cell surface receptors and producing its effects.
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Other evidence agreeing with ganglioside Gmi being the toxin
receptor came from the work of Cuatrecasas (1973b) who
showed that there is a 10-fold increase in the response of
fat cells to toxin after preincubation of cells with
ganglioside. Pigeon erythrocytes were also made more
responsive to toxin by preincubation with ganglioside (Gill
and King, 1975; King et al., 1976). The best evidence came
from using cells in culture whose ganglioside content could
be measured and altered artificially. Hollenberg et al.
(1974) looked at toxin binding in three different mouse cell
lines transformed with viruses and found a correlation
between the ganglioside Gmi content, toxin binding and the
activation of adenylate cyclase.
1.3.2 Interaction of the B subunit with ganglioside Gmi
The first indications that the B subunits were responsible
for the binding of the toxin to ganglioside Gmi came from
observations that choleragenoid protects cells and intact
loops of small intestine (Pierce, 1973) from the action of
the toxin (Cuatrecasas, 1973a; van Heyningen, 1974; Holmgren
et al., 1974; Gill and King, 1975). This is probably due to
the ganglioside binding sites being occupied by subunit B
and so not available for reaction with the toxin.
Cholera toxin was found to bind 4 (Sattler et al., 1978) or
5-6 (Fishman et al., 1978) molecules of the oligosaccharide
portion of ganglioside Gmi, indicating that each B subunit
has one binding site for the ganglioside. The terminal
galactose residue of ganglioside Gmi was shown to be
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involved in the binding of cholera toxin by Mullin et a 1.
(1976) and is protected by toxin from modification by
galactose oxidase and subsequent reduction with 3H-labelled
sodium borohydride (Mullin et al., 1976). Subunit A does
not bind ganglioside, at least no more so than most other
proteins and gangliosides, presumably because of hydrophobic
interactions.
1.3.3 Entry of the toxin into the cell
The active Ai peptide of the toxin must penetrate the cell
membrane in order to gain access to the adenylate cyclase
which is located on the cytoplasmic surface of the membrane.
Unfortunately, the mechanism by which this occurs is still
not known.
A lag phase of 15-90 minutes, depending on the cell type and
conditions of incubation, has been observed between the
binding of the toxin to the cell and the increase in
activity of adenylate cyclase (Cuatrecasas, 1973c; Bennet
and Cuatrecasas, 1975; Gill and King, 1975; Fishman, 1980).
This was suggested to be due to the time taken for the Ai
peptide to dissociate from the toxin molecule and enter the
cell. Confirmation came in 1975 (van Heyningen and King;
Gill and King) when there was shown to be no lag in lysed
pigeon erythrocytes, where the toxin had immediate access to
adenylate cyclase, and that the Ai peptide alone was
sufficient to activate the cyclase.
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1.3.4 Models for the entry of the Ai chain
As previously mentioned in order to activate adenylate
cyclase all or part of subunit A must be transported to the
cytoplasmic surface of the membrane. There have been
several theories put forward as to how this might occur.
The simplest is that suggested by van Heyningen and King
(1975), who observed that subunit A is active alone with
intact cells. They proposed that there is no specific
mechanism of entry, but that a high local concentration of
toxin bound to ganglioside would increase the chance of a
few molecules entering by some random process. Once inside
the cell the Ai-A2 disulphide bond may be cleaved by the
thiol:protein disulphide oxidoreductase enzyme, which is
found associated with membranes (Moss et al., 1980). The
main argument against this is that proteins, especially
hydrophilic ones, are not thought to cross cell membranes by
themselves to enough of an extent to account for the
observed activity of the toxin.
Another theory is that of Gill (1976a) who proposed that the
five B subunits dissolved in the membrane forming a
hydrophilic channel through which the A subunit could pass.
Also experiments with lipid bilayers showed that the toxin
could induce permeability changes, perhaps indicating the
formation of a pore or channel (Moss et al., 1977; Tosteson
and Tosteson, 1978). However, this has been ruled out, in
this form at least, since photoaffinity labelling
experiments (Wisnieski and Bramhall, 1981) and x-ray
diffraction analysis (Ribi et al . , 1988) shows no evidence
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of membrane penetration by the B subunits. A modification
of this theory is that the B subunits might combine with a
preexisting carrier protein already present in the membrane
thus forming the required channel (Gill, 1978).
Another possibility is that entry is by endocytosis,
although the problem here is that the endocytosed protein
is still separated from the cytoplasm by a membrane.
However, there is little evidence for this even though some
endocytosis has been observed (Manuelidis and Manuelidis,
1976; Hansson et al., 1977). Toxin taken up in this way
does not seem to be active with intact cells. Also, it
would be expected that a protein binding tightly and in
large amounts to the cell surface would be endocytosed at
least to some extent. It is harder to show that the
endocytosis is a prerequisite for activity.
It has also been suggested that the Ai fragment traverses
the membrane by direct interaction with the hydrophobic
interior of the bilayer (Tomasi and Montecucco, 1981;
Wisnieski and Bramhall, 1981). However, whether the whole
of the Ai chain has to penetrate the membrane is not very
clear since small proteolytic fragments are claimed to show
activity (Matuo et al., 1976; van Heyningen and Tait, 1980).
Van Heyningen (1977b) reported that cross-linked cholera
toxin as well as native toxin could activate adenylate
cyclase in intact cells, suggesting that the Ai peptide does
not necessarily dissociate from the rest of the toxin as it
passes through the membrane. Most people assume the 5B-A2
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component remains outside the cell (Wisnieski and Bramhall,
1981), although some cells, such as neuronal cells, take up
the whole toxin (Joseph et al., 1978).
1.4 Effects of cholera toxin
A diagrammatic representation of some of the reaction
processes occuring in the intestinal cell is shown in Figure
1-2, and they are discussed in the following sections.
1.4.1 ADP-ribosylation and activation of adenylate cyclase
The enzyme adenylate cyclase is a complicated protein
consisting of three components, namely the hormone receptor,
the catalytic unit responsible for synthesizing cyclic AMP
from ATP and the regulatory component that binds guanine
nucleotides. This regulatory component has various names
including GTP-binding protein, G protein (because it binds
guanine nucleotides), N protein (because it binds
nucleotides) and G/F protein (because it is responsive to
both guanine nucleotides and fluoride). There are at least
two types of regulatory proteins, one of which stimulates
the catalytic subunit of adenylate cyclase, Gs, and another
of which inhibits, G, . Cholera toxin activates adenylate
cyclase via Gs, while pertussis toxin activates via Gi .
The role of GTP in the regulation of adenylate cyclase was
first recognized by Rodbell et a1. (1971), who used it to
restore hormone sensitivity to the cyclase in isolated
membranes. Moss et al. (1976) discovered that cholera toxin
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Fig. 1-2 The intestinal epithelial cell.
(Based on a diagram given to me by H R de Jonge)
A1 - active Ai peptide of cholera toxin; Ns and
Ni - stimulatory and inhibitory regulatory
subunits of adenylate cyclase; ADPR - Adenosine
diphosphoribose; AC - adenylate cyclase; cAMP -
adenosine 3/,5/-cyclic monophosphate; GC -
guanylate cyclase; cGMP - guanosine 3/,5/-cyclic
monophosphate; A-kinase - cAMP-dependent protein
kinase; G-kinase - cGMP-dependent protein kinase;
C-kinase - protein kinase C; CaM - calmodulin; ER
- endoplasmic reticulum; PL-C - phospholipase C;
PI-4,5P2 - phosphatidyl inositol 4,5-bisphosphate;
IP3 - inositol 1,4,5-trisphosphate; DAG -














catalyzed the hydrolysis of NAD+ to ADP-ribose and
nicotinamide (NAD+-glycohydrolase activity). Moss and
Vaughan (1977) further demonstrated that the release of
nicotinamide from NAD+ was greatly stimulated by D- or L-
arginine. ADP-ribosyl-L-arginine was formed as a product
when L-arginine was present. In 1977 Levinson and Blume
showed that cholera toxin activation of the cyclase was
dependent on GTP as well as NAD+.
Although much of the NAD+-glycohydrolase activity of the
crude toxin may be due to another enzyme (Tait and van
Heyningen, 1978) it is clear that both NAD+-glycohydrolase
and ADP-ribosyl transferase activities are true properties
of the Ai peptide of the toxin. Reported Km values for NAD+
using artificial acceptors are 3.6 mM (Mekalanos et al.,
19 79a) and 5 mM (Moss et al . , 1979).
Pfeuffer (1977) was the first to identify a GTP-binding
protein of molecular mass 42 kDa using a photoreactive GTP
analogue. This regulatory component could be separated from
the catalytic unit by affinity chromatography on GTP-
Sepharose. The cyclase depleted of this component did not
respond to guanosine 5/-[ jjf^-imido ] triphosphate (Gpp(NH)p),
a non-hydrolysable GTP analogue, or to fluoride ions, but
response was restored when the isolated regulatory component
was added. This showed that the ADP-ribosylation of this
regulatory component by cholera toxin was the basis of
activation of adenylate cyclase.
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It was shown that when [adenylate-32P]-NAD+ was supplied,
cholera toxin catalyzed the ADP-ribosylation of specific
proteins (both soluble and membrane bound) in pigeon
erythrocytes (Cassel and Pfeuffer, 1978; Gill and Meren,
1978; Gill, 1979). The principal ADP-ribosylated protein
was the one of 42 kDa identified by Pfeuffer (1977).
As far as different tissues and cells are concerned, cholera
toxin has been generally found to catalyze the ADP-
ribosylation of proteins with a molecular mass of 42-56 kDa,
some of which have been identified as the regulatory
component of adenylate cyclase (for a general review see
Enomoto and Gill, 1983).
The protein of 42 kDa now seems to be a subunit of Gs
(Katada and Ui, 1982a). The two regulatory proteins, Gs and
Gi , have been purified (Sternweis et al . , 1981; Bokoch et
al . , 1983, 1984; Codina et al., 1983, 1984) and appear to be
similar both structurally and functionally. They both
consist of oCpy heterotr imers (Hildebrandt et aI., 1984) of
molecular mass 80-90 kDa (Bokoch et al., 1984; Codina et
al . , 1984). Their ot (42-45 kDa for Gsot and 41 kDa for Gio*.)
and NT <35 kDa for J3 and 5-10 kDa for y) subunits are
heterogeneous, but the heterogeneity of the py subunits may
be due to stable combinations of similar p subunits with
different V subunits (Neer and Clapham, 1988). Indeed,
cells other than retinal cells have been found to contain
two closely-related p subunits, a major 36 kDa form and a
minor 35 kDa form (Roof et al., 1985; Evans et al., 1987),
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whereas Evans et al. (1987) have defined two types of non
retinal y subunits. Therefore, the existence of at least
two forms of p, and y subunits means that there are at least
four possible stable combinations in non retinal cells.
The oc subunits of both proteins bind GTP (Northup et al.,
1982), whereas the and/or y subunits are probably
responsible for anchoring the c* subunit to the plasma
membrane (Sternweis, 1986). Activation of either protein
(Gs and G, ) is guanine nucleotide- and Mg2+-dependent
(Northup et al., 1982; Hildebrandt and Birnbaumer, 1983), is
also brought about by sodium fluoride in the presence of
Mg2+ ions (Sternweis et al . , 1981) and appears to result in
the dissociation of the proteins into separate ot and
components (Hildebrandt et al. , 1983; Bokoch et al., 1983;
Northup et al., 1983a; Kahn and Gilman, 1984a). Gs and Gi
are substrates for bacterial toxin catalyzed NAD+-dependent
ADP-ribosylation (Fig. 1-3). The c* subunit of Gs (GSoi) is
ADP-ribosylated by the Ai peptide of cholera toxin.
Specifically Ai transfers the ADP-ribosyl group from NAD+ to
an arginine residue of Gs <*. (Gill and Meren, 1978; Cassel and
Pfeuffer, 1978). Cassel and Selinger (1977) have shown that
adenylate cyclase is active while GTP is bound to the GTP-
binding component, but reverts back to an inactive state as
GTP is hydrolysed to GDP by its inherent GTPase activity.
The effect of cholera toxin is to inhibit this GTPase
activity, thus prolonging the active state of the G protein
(Cassel and Selinger, 1977). This stabilizes adenylate
cyclase in an active conformation, producing increasing






















Fig. 1-3 Mechanism for the ADP-ribosylation of the
G protein, the regulatory component of
adenylate cyclase, by cholera toxin.
-28-
As well as ADP-ribosylation playing an important role in the
activation of adenylate cyclase by certain bacterial toxins,
it is becoming evident that it is also important in
maintaining the level of cyclic AMP within the cell. In
1986, while looking at the ADP-ribosylation of adipocyte
plasma membranes by cholera and pertussis toxins, Jacquemin
et al. found endogenous ADP-ribosylation of Gs as a result
of the sustained stimulation of Gi by adenosine during the
incubation of control cells. Their results indicate that
there may be a possible homeostatic mechanism in which the
autonomous adjustment of the basal activity of Gs as a
function of that of Gi , under the control of any feedback
inhibitory ligands, ensures that there is a steady
production of cyclic AMP in the cell.
Less progress has been made in the characterization of the
catalytic component of adenylate cyclase. However, the
purification of a protein of molecular mass 130-150 kDa has
been reported (Coussen et al., 1985; May et al., 1985;
Pfeuffer et al., 1985; Yeager et al . , 1985; Smigel, 1986).
The theory of the sequence of events producing the hormonal
stimulation of adenylate cyclase is shown in Figure 1-4 A,B
and summarized as follows (Gilman, 1984a). The binding of
the hormone, H, to its receptor, Rs , causes a conformational
change in the receptor which is transmitted to Gs, making it
susceptible to binding by GTP. When GTP binds, the G
protein takes on a different conformation leading to the










Fig. 1-4 Mechanism of activation of adenylate cyclase
by cholera toxin.
(A) Scheme showing the activation of adenylate
cyclase by a hormone, H, binding its receptor,
Rs, and by cholera toxin (Adapted from
van Heyningen, 1982).
(B) Scheme showing the interaction of the
subunits of the Gs protein with the catalytic
component, C, of adenylate cyclase to produce
the active catalytic form, C* (Adapted from
Gilman, 1984a).
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GTP-occupied c< subunit (GSo<) can then bind and activate the
catalytic subunit (Fig. 1-4 B), producing cyclic AMP from
ATP. In fact it has been shown by Northup et al. (1983b)
that the (S.+X subunits inhibit adenylate cyclase as a result
of their interaction with the c* subunit. Activation of the
cyclase is terminated by the specific GTPase activity
(Cassel and Selinger, 1976) which resides in the o< subunit
(Stadel and Lefkowitz, 1983; Gilman, 1984a,b; Schramm and
Selinger, 1984), resulting in the re-association of the
subunits and a return to the inactive state (Fig. 1-4 A).
The effect of cholera toxin can then be simply explained by
its ability to prolong the life of the activated GS«*-GTP
complex so that increasing amounts of cyclic AMP are
produced, independently of stimulatory receptors and ligands
(Cassel and Pfeuffer, 1978; Gill and Meren, 1978; Johnson et
aI., 1980).
1.4.2 Cofactor requirements for ADP-ribosylation
As well as NAD+ (Gill, 1975) and GTP (Gill, 1976b; Enomoto
and Gill, 1979), a cytosolic factor with a molecular mass of
about 20 kDa (Enomoto and Gill, 1979, 1980) was found to be
required for the rapid ADP-ribosylation of the Gs protein.
Once the Gs protein had been purified from various membranes
(Northup et al., 1980; Sternweis et al., 1981; Hanski et
al., 1981) the requirements for cholera toxin-catalyzed ADP-
ribosylation could be properly investigated. An intrinsic
membrane protein that is required for the cholera toxin-
dependent ADP-ribosylation of purified Gs (Schleifer et al.,
1982) has been purified about 2000-fold from cholate
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extracts of rabbit liver membranes (Kahn and Gilman, 1984b).
This protein, termed ARF (ADP-Ribosylation Factor), has a
molecular mass of 21 kDa and was found to have a high-
affinity binding site for guanine nucleotides (Kahn and
Gilman, 1986). The binding of GTP or GTPjfS (a non-
hydrolyzable GTP analogue) to ARF is necessary for the
activity of the cofactor (Kahn and Gilman, 1986). Kahn and
Gilman (1984b) proposed that a Gsoi.ARF complex served as the
cholera toxin substrate. However, it has recently been
shown by Tsai et al. (1987) that bovine brain ARF enhances
not only the ADP-ribosylation of GSo< but also Gs<x-
independent cholera toxin-catalyzed reactions. These are
the hydrolysis of NAD+, the ADP-ribosylation of low
molecular weight guanidino compounds such as agmatine, the
ADP-ribosylation of several proteins unrelated to Gs«. and
the auto-ADP-ribosylation of the toxin Ai peptide. These
reactions as well as the ADP-ribosylation of ARF itself were
stimulated by GTP or stable GTP analogues. These
observations are consistent with the direct interaction of
ARF with cholera toxin in a GTP-dependent manner enhancing
the catalytic activity of the aforementioned reactions. Two
soluble proteins (sARFl and sARF2) from bovine brain that
also enhance the Gsoc-dependent and -independent ADP-ribose
transfer reactions catalyzed by the toxin have also been
purified and characterized (Tsai et al., 1988). As with the
membrane ARF (mARF), both soluble factors are 19 kDa
proteins dependent on GTP or GTP analogues for activity. It
appears that these soluble factors, like mARF, directly
activate cholera toxin in a GTP-dependent way.
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A second guanine nucleotide binding site, termed S, was
described in 1983 by Gill and Meren. They showed that the
binding of nucleotide to S is promoted by a cytosolic
protein factor, which they named CF. In 1987, Gill and
Coburn showed that non-hydrolyzable GTP analogues have a
stable effect on S allowing the CF-directed activation of S
to be separated temporally from the assay of the effect of
activated S on ADP-ribosylation rates. They believe ARF
(Schleifer et al . , 1982; Kahn and Gilman, 1984b) and S are
the same protein, but despite earlier suppositions (Gill and
Meren, 1983; Kahn and Gilman, 1984b) that ARF/S interacts
with Gs the data shows that the direct activation of cholera
toxin by ARF/S is more likely, in agreement with Tsai et al.
(1987, 1988).
1.4.3 Cyclic-nucleotide-dependent protein phosphorylation
and intestinal secretion
The movement of electrolytes across the small intestinal
epithelium (Kimberg, 1974; Field, 1976) which can be caused
by the enterotoxins of Vibrio cholerae and Escherichia coli
and hormones such as glucagon, vasoactive intestinal peptide
(Schwartz et al., 1974), vasopressin and several
prostaglandins is mediated by at least three intracellular
signals: (1) cyclic AMP, resulting from the increase in
activity of adenylate cyclase by cholera toxin, which exerts
its effect through the activation of intestinal cyclic-AMP-
dependent protein kinase (Alhanaty and Shaltiel, 1979), (2)
cyclic GMP, produced by guanylate cyclase in the brush
border membrane and which activates cyclic-GMP-dependent
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protein kinase (de Jonge, 1981), and (3) calcium, probably
acting through calmodulin (Ilundain and Naftalin, 1979) or
through a phospholipid-dependent (protein kinase C) protein
kinase (de Jonge, 1983). Although there may be cyclic
nucleotide- and Ca2+-sensitive carriers operating in the
basal-lateral membranes of intestinal cells (Brown et al.,
1983) and in the tight junctions (Bakker and Groot, 1983),
the major secretory response is thought to occur in the
brush border membrane (Frizzell et al. , 1979). The
potential cyclic nucleotide- and Ca2+-sensitive ion
transport carriers in epithelial membranes include (1) an
electroneutral Na+-CI- cotransporter in intestinal brush
border membranes (Frizzell et al., 1979; Fan et al., 1983).
The nature of the coupling of the Na+ to CI- transport is
unclear. However, Fan et al. (1983) proposed, as did
Liedtke and Hopfer (1982a,b), that rather than there being a
direct coupling of Na+ to CI" it might be Na+/H* and Cl-/0H~
(or HCO3") antiporters which account for the comovements of
Na+ and CI- (an influx) across the villus cell brush border
membrane. (2) A Cl~ channel in the brush border membrane,
probably localized in crypt cells and maybe lower villus
cells (Frizzell et al., 1979; Welsh et al., 1982). (3)
transport systems occuring in the basal-lateral membranes
which facilitate active CI- secretion, for example a coupled
entry mechanism for Na+-CI" (Frizzell et al . , 1979), the
Na+,K+ pump (Hootman et al., 1983), and Ca2+-regulated K+
channels (Brown et al., 1983).
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Since the biological effects of cyclic nucleotides may be
mediated through the regulation of the activity of protein
kinases (Kuo and Greengard, 1969; Shlatz et al . , 1978), and
the cyclic-nucleotide-dependent protein kinases are integral
components of plasma membranes in a wide variety of tissues
(Rubin et al., 1972; Ueda et al., 1973; Forte et al., 1975;
Azhar and Menon, 1975), it seems likely that the
phosphorylation and dephosphorylation of unique membrane
proteins could provide the mechanism for the regulation of
membrane function and structure. Indeed, there has been
good evidence showing an effect of cyclic nucleotides on the
phosphorylation of small intestinal brush border membranes
(Lucid and Cox, 1972; de Jonge, 1976,1981; Shlatz et al . ,
1978, 1979). Van Dommelen and de Jonge (1984) have shown
evidence for a CI- channel in intestinal brush border
membranes activated by the cyclic-AMP-dependent
phosphorylation of one or more membrane proteins. In 1972
Lucid and Cox found that there was an enhanced incorporation
of 32P in brush border membranes after treatment with
cholera toxin by an in vivo method. However, because they
measured the total 32P-incorporation by liquid scintillation
counting it is impossible to say if any unique proteins are
phosphorylated in the presence of cholera toxin. Later, de
Jonge (1976) found that a protein of molecular mass 86 kDa
dependent protein kinases
was phosphorylated by both cyclic AMP- and cyclic GMP-J[in rat
intestinal brush border membranes. However, he did not look
at any effects on the basal-lateral membrane. Therefore, in
1978 Shlatz et al. looked to see if the purified plasma
membranes of rat enterocytes (brush border versus basal-
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lateral) had the necessary components for phosphorylation:
an endogenous cyclic-nucleotide-dependent protein kinase,
endogenous protein substrates, and a phosphoprotein
phosphatase. They found that although both membranes were
phosphorylated by an endogenous protein kinase and contain a
phosphoprotein phosphatase, the brush border membranes were
phosphorylated and dephosphorylated to a greater extent than
the basal-lateral membranes. However, in contrast to these
results Scalera et al. (1983) found no evidence for the
cyclic-AMP-dependent phosphorylation of a brush border
membrane protein, either by the perfusion of rat jejunum in
vivo with [32P]orthophosphate or by the in vitro
phosphorylation of brush border membranes by [y-32P]ATP,
both in the presence of cholera toxin. They, therefore,
came to the conclusion that the alteration in NaCl absorption
caused by cholera toxin was probably not mediated via cyclic
AMP protein kinase activity, which would lead to an altered
protein phosphorylation of brush border membranes.
Evidence has accumulated suggesting that calcium is a
physiological regulator of intestinal electrolyte transport
(Bolton and Field, 1977). Conditions which increase
intracellular calcium, such as the use of the calcium
ionophore A23187 (Frizzell, 1977), cause the stimulation of
intestinal chloride secretion and inhibition of sodium
chloride absorption. To the contrary, exposure to the
calcium channel blocker verapamil, to decrease the
intracellular calcium concentration, stimulates sodium
chloride absorption (Donowitz and Asarkof, 1980).
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Calmodulin is thought to be involved in these effects since
the antipsychotic drug trifluoperazine (see section 1.4.4),
which binds calmodulin tightly, inhibits the intestinal
secretion caused by calcium ionophore A23187 (Smith and
Field, 1980). On the basis of 2 2 Na+ and 36C1- isotope flux
experiments in rabbit brush border membrane vesicles, Fan
and Powell (1983) have reported that Ca2+ and Ca2 + -
calmodulin inhibit microvillar Na+-CI- transport.
Interestingly though, protein phosphorylation was not
apparently involved in this regulatory mechanism. Having
said this, the authors do speculate that the protein kinase-
mediated phosphorylation of membrane proteins might be
responsible for the inhibition of Na+-CI- transport, since
Taylor et al . (1981) have reported the Ca2 +/calmodulin¬
sensitive phosphorylation of rabbit ileal membrane proteins.
Since calcium and calmodulin affect phosphorylation and the
function of specific proteins in several other systems
(Schulman and Greengard, 1980), it seems likely that
Ca2*/calmodulin-sensitive as well as cyclic-nucleotide-
sensitive phosphorylation is a control mechanism for
electrolyte transport.
1.4.4 Effect of antidiarrhoeal drugs
A certain class of drugs known as the phenothiazines, which
are antipsychotic drugs, have been found to inhibit the
diarrhoea caused by cholera toxin by mechanisms which are
not yet fully understood. However, the main sites of action
at which they are thought to affect membrane transport are
adenylate cyclase, calmodulin and protein kinases.
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As mentioned in the previous section the concentration of
calcium has been implicated in the control of ion secretion
and the acidic, heat stable, Ca2+-binding protein calmodulin
has been suggested to be important in mediating these events
(Fan and Powell, 1983). Calmodulin appears to be able to
bind four Ca2+ ions, and upon binding Ca2t its conformation
changes exposing hydrophobic regions (La Porte et al. , 1980)
and increasing its helical content (Liu and Cheung, 1976).
It is this conformational change which allows binding of the
calmodulin-Ca2+ complex to specific sites on enzymes, thus
increasing their activities by an unknown mechanism. The
binding of Ca2+-activated calmodulin activates a number of
Ca2+-dependent enzymes including a specific molecular form
of phosphodiesterase (Uzunov and Weiss, 1972), adenylate
cyclase (Amiranoff et al., 1983), guanylate cyclase,
(Ca2++Mg2+)-ATPase (Caroni and Carafoli, 1981),
phospholipase A2 (Wong and Cheung, 1979) and protein kinases
(Srivastava et al., 1979; Kennedy and Greengard, 1981). It
has been shown that the phenothiazines bind to calmodulin in
a Ca2+-dependent manner with both a high affinity and
specificity, and so this has been proposed as a mechanism of
their action (Levin and Weiss, 1977, 1978; Weiss and Levin,
1978; La Porte et al., 1980); there are one to three Ca2+-
dependent drug binding sites per calmodulin molecule. In
fact a correlation between the high affinity for calmodulin
and the antisecretory activity of many drugs has been shown.
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There appear to be two kinds of interactions between the
drugs and calmodulin: (i) a hydrophobic interaction between
a lipophilic portion of the drug and a non-polar region of
calmodulin and (ii) an electrostatic interaction between a
positively charged amino group on the drug and a negatively
charged acidic residue on calmodulin (Prozialeck and Weiss,
1982; Weiss et al., 1982). The most potent inhibitors of
calmodulin have a very large hydrophobic region, consisting
of two aromatic rings, joined at one or two positions, a
side-chain amino group that is at least four atoms removed
from the aromatic ring structure and the addition of a
moiety on the aromatic ring to increase its hydrophobicity
(Prozialeck and Weiss, 1982; Weiss et al. , 1982).
The pharmacological actions of the phenothiazines on the
central nervous system are quite varied; these include
antipsychotic, sedative and extrapyramidal effects. These
drugs also influence the neuroendocrine, gastrointestinal
and cardiovascular systems, particularly when used in high
concentrations (Weiss et al., 1982). Since calmodulin
influences a wide variety of cellular events, particularly
nervous, muscular and secretory systems, its inhibition may
provide a common mechanism for explaining some of the
diverse biochemical actions of the drugs. Although the
phenothiazine antipsychotics are among the most potent
calmodulin inhibitors there are several other
pharmacological classes of drugs that can also inhibit
calmodulin (see Weiss et al., 1982); these include
ot-adrenergic antagonists (Earl et al., 1982), antimalarials
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(Volpi et al . , 1981), cancer chemotherapeutic agents (Katoh
et al . , 1981), antihistaminics (Weiss et aI . , 1980),
antidepressants (dibenzazepines) (Levin and Weiss, 1976),
antianxiety agents (benzodiazepines) (Levin and Weiss, 1978;
Weiss et al., 1980) and antipsychotic drugs belonging to
other chemical classes, particularly diphenylbutylpiperi-
dines, the thioxanthenes and, to a lesser extent, the
butyrophenones, dibenzazepines and dibenzodiazepines (Levin
and Weiss, 1978; Weiss et al., 1980).
However, since calmodulin has such a diverse regulatory
action, how can a drug which inhibits calmodulin have a
specific action? The answer could be that (i) the
specificity with which calmodulin inhibitors act depends on
drug disposition, localization, binding and transport across
specialized membranes and (ii) maybe a different
concentration of calmodulin is required to activate the
different Ca2+-dependent enzymes. If this is true then a
calmodulin inhibitor might exert a greater effect on one
calmodulin-dependent process than another.
Various drugs have been investigated both for their capacity
as antidiarrhoeal agents and as inhibitors of calmodulin
activity. Chlorpromazine, a phenothiazine, has been
reported to inhibit the hormonal stimulation of adenylate
cyclase in various tissues (Kakiuchi and Rail, 1968; Wolff
and Jones, 1970; Osnes et al . , 1976). This prompted
Lonnroth et al. (1977) to look at the effects of this drug
on the cholera toxin activation of adenylate cyclase in
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mouse thymocytes in vitro and cholera-toxin-induced
intestinal secretion in mice in vivo. They found that
chlorpromazine inhibited the formation of cyclic AMP, and
prevented intestinal hypersecretion in response to cholera
toxin. The decrease in cyclic AMP formation is not likely
to be due to an increase in phosphodiesterase-induced cyclic
AMP degradation, since the drug has been reported to inhibit
rather than enhance the activity of phosphodiesterase in
other systems (Wolff and Jones, 1970). Holmgren et al.
(1978) examined the antisecretory activity of chlorpromazine
more closely. They found that this drug inhibits the
intestinal secretion caused by various diarrhoeagenic agents
(E. coli heat-labile enterotoxin, prostaglandin Ei and
dibutyryl cyclic AMP) which are known to act through cyclic
AMP (Pierce and Wallace, 1972; Kimberg, 1974; Field, 1976),
and also turns off already established secretion without
appearing to have any effect on absorption. They also found
that these effects were associated with the marked
inhibition of adenylate cyclase as well as protein kinase
activities of mouse small intestinal epithelial membranes.
Fluoride-stimulated adenylate cyclase activity was also
inhibited, whereas basal activity was relatively unaffected.
Clinical trials came in 1979 when Rabbani et al. found that
chlorpromazine effectively reduced the fluid-loss in eleven
cholera patients with severe purging. However, they do say
that this drug does have some undesirable side-effects,
particularly lowered blood-pressure, and so must be
investigated further. After all the drug could be
potentially dangerous when given to dehydrated patients and
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patients undergoing rehydration by oral replacement in a
somewhat less supervised setting. After finding that
trifluoperazine, a phenothiazine, and several other related
drugs which bind to calmodulin inhibit the CI- ion secretion
associated with the diarrhoea induced by agents such as
cholera toxin, prostaglandins and vasoactive intestinal
peptide (Ilundain and Naftalin, 1979; Sandhu et al., 1979;
Smith and Field, 1980), more intensive work was carried out
investigating the relationship between the effect of drugs
on calmodulin binding and antisecretory activity.
Prozialeck and Weiss (1982) looked at the abilities of
various phenothiazine derivatives to inhibit the calmodulin-
induced activation of phosphodiesterase in vitro, whereas
Lonnroth et al. (1980) and Zavecz et al . (1982) investigated
the effect of various phenothiazines and related drugs,
having different binding capacities to calmodulin, for
intestinal antisecretory activity. The results showed a
positive correlation between the affinity of the drugs
tested for binding to calmodulin and their ability to
inhibit intestinal fluid secretion.
Thus, the modification of calmodulin activity might explain
the pharmacology of drugs which are currently in use or
suggest novel approaches for pharmacologically regulating
various physiological processes (Weiss et al . , 1982).
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1.5 Other toxins
There are three main ways in which bacterial toxins show
similarities: in their two-component structure, in their
binding to the cell and in their mechanism of action.
Examples of toxins affecting eukaryotic cells by ADP-
ribosylation, like cholera toxin, are diphtheria toxin,
pertussis toxin, the heat labile toxin of E. coli and
exotoxin A of Ps. aeruginosa. These and the two
neurotoxins, tetanus and botulinum, are discussed in the
following sections. Similarities between the bacterial
toxins are shown in Table 1-1.
1.5.1 E. coli heat-labile toxin
Certain entero-pathogenic strains of Escherichia coli
secrete a heat-labile protein toxin ( LT) which activates
adenylate cyclase and induces diarrhoea in exactly the same
way as cholera toxin. E. coli toxin has the same subunit
structure as cholera toxin (Clements et al., 1980), produces
a peptide similar to Ai and catalyzes the ADP-ribosylation
of a susceptible arginine on Gs (Evans et al., 1972; Gill et
al . , 1981; Moss and Vaughan, 1981). Subunits of both toxins
cross-react immunologically and are highly homologous
(Moseley and Falkow, 1980; Spicer et al . , 1981; Spicer and
Noble, 1982; Dykes et al . , 1985). There seems to be little
doubt that the two toxins are evolutionarily related.
1.5.2 Diphtheria toxin
Diphtheria toxin is synthesized and secreted by
Corynebacterium diphtheriae as a single polypeptide chain
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Table1-1hcomponentstructurefvarioustoxi s( d dfr maHeyningen,1984) ToxinActivecompon ntBindingcompo ent Mol.wt. ofStructureM l.wt.TargetStructureol. t. toxin
i
Affectingadenylate cyclase Cholera82000 E.coliheatlabile91000 Pertussis Affectingprotein synthesis Diphtheria Ps.aeruginosa exotoxinA Neurotoxins Tetanus Botulinum
117000 62000 71000 150000 150000
SubunitA =A1peptide +A2peptide SubunitA =A1peptide tA2peptide S-l Achain Afragment Lchain Lchain
27000 22000 5000 30000 25000 5000 28000 24000 27000 50000 50000
Gsproteinof adenylate cyclase Gsproteinof adenylate cyclase Giproteinof adenylate cyclase EF2 (diphthamide) EF2 (diphthamide) Noclear function Noclear function
FiveBsubunits FiveBsubunits S-2 S-3 TwoS-4 S-5 Bchain Bfragment Hchain Hchain
11600 each 11800 each 23000 22000 11700 9300 each 38000 45000 100000 100000
Gangliosidemi Gangliosidemi and glycoproteins Notknown, maybea glycoprotein Glycoprotein Hasnoclear function Ganglioside Gtib,d1 Notknown,may beaglycolipid
that can be cleaved proteolytically into two chains
(fragments A and B). Diphtheria is an upper respiratory
infection caused by bacteria lodged in the throat or
nasopharynx where they cause the formation of a
pseudomembrane over the pharynx, nasopharynx and upper
trachea. This may lead to death by suffocation. In
addition to the infection, muscle weakness and lethargy are
observed, and death is often ascribed to heart failure.
Fragments A and B are held together by a single disulphide
bond and both the intact and cleaved toxin are toxic.
Fragment A catalyzes the ADP-ribosylation of elongation
factor 2 (EF-2), thus inhibiting ribosomal protein synthesis
(Hon.jo et al . , 1968; Collier and Cole, 1969; van Ness et
al., 1980a). As with Gs, EF-2 has GTPase activity which is
destroyed by ADP-ribosylation, preventing protein synthesis
and leading to cell death (Honjo et al.,1968). Unlike
cholera toxin, diphtheria toxin catalyzes the ADP-
ribosylation of diphthamide, a modified histidine (2 — [3 —
carboxyamido-3-(trimethylammonio)-propyl]histidine) which
has so far been only found in EF-2 (van Ness et al. ,
1980a,b).
1.5.3 Ps. aeruginosa exotoxin A
Pseudomonas aeruginosa infections often follow wounding or
burning. Exotoxin A of the bacterium shares strong
analogies with diphtheria toxin (Vasil et al.,1977). The
structure of the protein has some similarities to that of
diphtheria toxin although they do not cross-react
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immunologically and the toxin also catalyzes the ADP-
ribosylation of EF-2 (Iglewski and Kabat, 1975; Iglewski et
al., 1977).
1.5.4 Pertussis toxin
Lymphocytosis promoting factor (LPF) is the major exotoxin
secreted by Bordetella pertussis, the pathogenic bacterium
causing whooping cough (Robinson et al. , 1985). Although
the bacterium secretes many other toxins, LPF is the most
important virulence factor and as such is more commonly
referred to as pertussis toxin. It is also known as islet-
activating protein (IAP) because of its unique action in
enhancing the insulin secretory responses of pancreatic
islet cells (Robinson et al., 1985). The characteristic
cough of this disease is caused by the bacteria colonizing
the ciliated mucosa of the upper respiratory tract.
Pertussis toxin is a hexamer (117 kDa) of five dissimilar
peptides (Tamura et al., 1982), having the same A(active)-
B(binding) structure as the other toxins. It catalyzes the
ADP-ribosylation of a 41 kDa protein (Katada and Ui, 1982a),
which correlates with the pertussis-toxin-induced activation
of adenylate cyclase resulting in an increase in cyclic AMP
(Katada and Ui, 1982b; Murayama and Ui, 1983; Kurose et al.,
1983). It is now known that the toxin acts by ADP-ribosyl-
ating the inhibitory guanine-nucleotide-binding protein of
adenylate cyclase, Gi (Ui, 1984). ADP-ribosylation
inactivates Gi thereby blocking the inhibition of adenylate
cyclase activity (Katada and Ui, 1982b; Bokoch et al., 1983;
Codina et al., 1983). The amino acid that is modified has
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been reported to be cysteine (West et al . , 1985; Lobban and
van Heyningen, 1988),
1.5.5 Tetanus toxin
Tetanus toxin is the neurotoxin secreted by Clostridium
tetani that is responsible for the dramatic muscular spasms
of the disease tetanus. Although this disease has been
known since the earliest days of medicine, relatively very
little is known about it in comparison to other bacterial
toxins. This is probably due to the fact that the target of
the toxin, the nervous system, is very complicated and is
itself not fully understood at the molecular level.
The first stage of the intoxication process is thought to be
the diffusion of the toxin through the extracellular fluid
from its point of entry (for example a cut) to the
neuromuscular junction, where it is taken up. Following
this internalization, the toxin is transported by retrograde
axonal transport (Price et al . , 1975) to the cell body, from
where it migrates trans-synaptically until it reaches the
inhibitory synapses of the spinal cord or brain stem. The
toxin is thought to act by the presynaptic blocking of the
release of inhibitory neurotransmitters, especially
y-aminobutyric acid (Curtis et al., 1973; Davies and
Tongroach, 1979) and glycine (Curtis and de Groat, 1968),
from these synapses. This results in the uninhibited firing
of motor neurones, which leads to the characteristic spastic
paralysis of the disease.
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1.5.6 Botulinum toxin
The various strains of Clostridium botulinum produce at
least eight different toxins. Seven of the eight toxins (A,
B, CI, D, E, F and G) are neurotoxic and block the release
of neurotransmitters at cholinergic but also at various
other synapses by a still unknown mechanism (Habermann and
Dreyer, 1986), resulting in the characteristic flaccid
paralysis of this disease. Botulinum C2 toxin is not
neurotoxic but cytotoxic and acts by ADP-ribosylating
isolated actin (Aktories et al . , 1986a,b) and actin in
intact cells (Reuner et al . , 1987), reducing the ability of
the microfilament protein to polymerize (Aktories et al.,
1986a). It has recently been shown that certain strains of
CI. botulinum type C produce a second ADP-ribosyltransfer¬
ase, C3, which is clearly distinct from the C2 toxin
(Aktories et al., 1987). The substrate of this C3 toxin
appears to be 21-24 kDa guanine-nucleotide-binding
protein(s) (Aktories and Frevert, 1987; Rosener et al.,
1987) found in various cell types (Aktories et al., 1987).
Botulinum neurotoxin D (Ohashi and Narumiya, 1987) and CI
(Ohashi et al., 1987) have also been reported to be able to
ADP-ribosylate an eukaryotic 21 kDa GTP-binding protein,
which is supposedly involved in the toxin inhibition of
exocytosis processes. However, Rosener et al. (1987)
suggest that the ADP-ribosylating activities of the CI and D
neurotoxins are merely due to contamination by C3.
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1.6 Aims of project
Over the past two decades, there has been a great increase
in our knowledge of the molecular mechanisms of the ADP-
ribosylating enterotoxins, such as cholera toxin (Gill,
1975; Moss et al., 1976) and the heat-labile toxin of
Escherichia coli (Moss and Richardson, 1978; Gill and
Richardson, 1980), as activators of adenylate cyclase (Sharp
and Hynie, 1971; de Jonge, 1975; Enomoto and Gill; 1983).
However, the toxins are active in essentially all eukaryotic
cells, and just about all of this work has been carried out
on cells other than those of the intestine (Gill and Meren,
1978; Cassel and Pfeuffer, 1978; Northup et al., 1980;
Beckner and Blecher, 1981; Raufman and Cosowsky, 1987),
where the toxin exerts its effect during the disease.
Interestingly, there is a problem in the activation of
adenylate cyclase by cholera toxin, which is that the toxin
binds to the brush border membrane of the intestinal
epithelial cell (Walker et al., 1974; Critchley et al.,
1981), while the catalytic component of adenylate cyclase is
reported to be located at the basal-lateral membrane (Murer
et al. , 1976; Walling et al., 1978), i.e. on the other side
of the cell. Using [adenylate-32P]NAD+ , Domfnguez et al.
(1985) have shown that cholera toxin catalyzes the ADP-
ribosylation of three proteins of molecular mass 40 kDa, 45
kDa and 47 kDa located in the brush border membrane of
rabbit small intestinal epithelial cells. However, they
could not demonstrate any similar effect with basal-lateral
membrane proteins. They also showed that the activation of
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adenylate cyclase by cholera toxin occured only with a crude
plasma membrane preparation, while neither brush border nor
basal-lateral membranes alone were responsive to the toxin.
These results suggest that the modification of proteins at
the brush border membrane (i.e. ADP-ribosylation) is a
requirement for the activation of adenylate cyclase at the
basal-lateral membrane. In contrast though, when fluoride
ions were used as the activator, adenylate cyclase was
activated in basal-lateral membranes, and to a greater
extent than in crude plasma membranes (Domfnguez et al.,
1985). Since sodium fluoride and cholera toxin both
activate via the regulatory component of adenylate cyclase
(Ross and Gilman, 1980), it would seem impossible for the
activation by fluoride to rise at the same time as the
activation by toxin falls during the preparation of basal-
lateral membranes from crude plasma membranes.
Research has also been carried out on the phosphorylation of
certain proteins which are found in the brush border and
basal-lateral membranes. In 1976 de Jonge described the
cyclic AMP- and cyclic GMP-dependent phosphorylation of a
brush border protein, from rat intestine, with an apparent
molecular mass of 86 kDa. However, he did not undertake any
studies with purified basal-lateral membranes.
The need for a good, effective pharmacological agent to
safely inhibit the intestinal secretion caused by cholera
toxin is obviously of extreme importance. Even a partially
effective antisecretory compound would be of considerable
-50-
value. Although oral replacement therapy with sugar-
electrolyte solutions is almost 100% effective in cases
where patients are suffering from mild or moderate
dehydration, it often fails when the secretion is very
intense (Nalin et al., 1968; Nalin and Cash, 1971). An
agent that could reduce the volume of fluid secreted by as
much as 30%, for example from 1000 ml to 700 ml per hour,
might make the difference between success and failure in the
oral treatment of cholera. The phenothiazine antipsychotic
drugs, for example chlorpromazine, have been found to
inhibit the diarrhoea caused by cholera toxin by mechanisms
which are not yet fully known (Lonnroth et al., 1977;
Holmgren et aI., 1978; Rabbani et al., 1979), but are
thought to affect membrane transport via calmodulin,
adenylate cyclase and protein kinases. Since the
phenothiazines and other related drugs have been shown to be
effective in reducing the fluid loss, characteristic of
cholera and other diarrhoeal diseases (Holmgren et al.,
1978; Lonnroth et al., 1980; Zavecz et al., 1982), it is
necessary to find out more about their mechanisms of action
with the long term view to the rational design of better
antidiarrhoeal drugs, which lack the sedative action of
drugs like chlorpromazine.
The first stage of the project involved obtaining intestinal
cells from rabbits, preparing a purified plasma membrane
fraction, separating brush border membranes from basal-
lateral membranes and then performing biochemical
experiments on them. Initially, the ADP-ribosylation of
proteins in each membrane fraction was investigated. This
was to determine which proteins are labelled, whether the
labelling is unique to a particular membrane and whether the
major protein labelled has the same molecular mass as the
regulatory component of adenylate cyclase. The effect of
cholera toxin and sodium fluoride on the activity of
adenylate cyclase, in each membrane fraction, was then
investigated. This was to see if activation is greater in
one membrane fraction compared to the other, and if the
pattern of activation in the fractions is the same with both
cholera toxin and sodium fluoride (sodium fluoride, a known
potent activator of adenylate cyclase, was used as a
comparison to the cholera-toxin-induced activation). The
next stage was to identify which proteins are phosphorylated
and in which membrane fraction this occurs, and to see if
this phosphorylation correlates with the increase in cyclic
AMP brought about by the activation of adenylate cyclase by
cholera toxin.
The effect of drugs, with known antidiarrhoeal and anti-
calmodulin activities, on the activation of adenylate
cyclase and ADP-ribosylation was investigated. This was to
determine the correlation between the affinity of the drugs
for calmodulin, their antisecretory activity and their
effects on adenylate cyclase activity and the ADP-






Cyclic [8-3H]AMP and [o(-32P]ATP were purchased from Amersham
International.
[^-32P]ATP and [adenylate-32P]NAD+ were from New England
Nuclear.
Adenosine deaminase (type II), cyclic AMP (sodium salt),
ADP (di-monocyclohexylammonium salt, grade V), ATP (disodium
salt, grade II), BSA (98-99% albumin), cholera toxin,
chromatographic alumina (neutral, type WN-3, activity grade
1), creatine phosphate (disodium salt hydrate, sigma grade
98-100%), creatine phosphokinase (type I), cytochrome c
(type VI), dithiothreitol, GTP (type II-S), INT, D-mannitol,
Mops, NADPH (tetrasodium salt, type I), ouabain
(Strophanthin G octahydrate), saponin, sigma 104 phosphatase
substrate, sodium succinate, sucrose and thymidine were from
Sigma Chemical Co.
Glucose GOD-perid reagent and NAD+ (Grade 1, 100%) were from
Boehringer Mannheim.
Hepes and isoniazid were from BDH chemicals.
3-Isobutyl-l-methylxanthine (Gold label) was from Aldrich
Chemical Co.
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The following materials, used for preparing the membrane
samples for examination by electron microscopy, were kindly
supplied by Dr D J S Hulmes of the Biochemistry Department,
University of Edinburgh: sodium cacodylate, propylene oxide,
paraformaldehyde, glutaraldehyde, osmium tetroxide, araldite
CY212, dodecenyl succinic anhydride and benzyldimethylamine.
All other reagents were of analytical grade.
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2.2 Methods
2.2.1 Preparation of membrane fractions
2.2.1.1 General method
Brush border membranes and basal-lateral membranes were
prepared from intestinal epithelial cells as described below
and as summarized in Figure 2-1.
One female white New Zealand rabbit was sacrificed by
cervical dislocation and the jejunum and ileum removed.
After cutting the intestine into smaller sections, each
piece was thoroughly rinsed with isotonic saline (0.9%
sodium chloride) and cut open along the mesenteric border.
Each piece was gently scraped with a glass slide to remove
the epithelial cells. After weighing the cells they were
suspended in approximately 20 vol. 50 mM-D-mannitol, 5 mM-
Hepes, pH 7.5, 0.25 mM-MgCl2, (Buffer I), and homogenized
with 20 strokes of a motor driven Potter-Elvehjem
homogenizer. All manipulations were carried out on ice.
Brush border and basal-lateral membranes were prepared by a
modification of the method of Murer et al. (1976). After the
removal of an aliquot for marker enzyme assays, the
homogenate was centrifuged at 300g (Beckman JA-14 rotor,
rJV, 9.5 cm) for 10 min to remove whole cells and cell
debris. This step was repeated. The resulting supernatant
was centrifuged at 2,000g (JA-14 rotor) for 10 min to remove
any nuclei and cell debris. The supernatant obtained from
this stage was centrifuged at 9,750g (JA-14 rotor) for 10
min to remove the mitochondria. A brown pellet was produced
with a fluffy white top layer. The supernatant was swirled
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Isolated epithelial cells
Homogenize 20 strokes in 20 vol. 50mM mannitol,
5mM Hepes, pH 7.5, 0.25 mM MgCI 2 (Buffer I).
5% homogenate
Centrifuge at 300g (Beckman JA-14 rotor, r av 9.5 cm)




and cell debris Centrifuge at 2000g (r av. 9.5 cm)




Centrifuge at 9750g (rav 9.5 cm)
for 10 min at 4 °C. Resuspend fluffy
white layer of P3 in S3 and repeat.
Centrifuge at 35000g
(Beckman 45Ti rotor, r av. 6.98 cm)
for 30 min at 4° C.
Mixed Plasma
Membranes
Homogenize 10 strokes in 20 ml Buffer I, add MgCI2
to 10 mM, leave on ice for 30 min with occassional stirring.
Centrifuge at 3000g (Beckman 50Ti rotor, rav 5.91 cm)





Fig. 2-1 Scheme for preparation of membrane fractions
The pellets and. supernatants produced at each
stage, n, of centrifugation are represented by
Pn and Sn.
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gently to remove this layer from the pellet and homogenized
with 5 strokes. This step was then repeated. The pellet
produced by centrifuging the resulting supernatant at
35,000g (Beckman 45Ti rotor, rav . 6.98 cm) for 30 min
consisted of a mixture of brush border and basal-lateral
membranes (the mixed plasma membrane fraction). The
supernatant produced at this stage, S4 (see Fig. 2-1), was
also retained for resuspending the final membrane pellets,
in order to provide any necessary cytosolic factors. The
mixed plasma membrane fraction was used for preparing the
two types of membrane by a Mg2 + -precipitation technique
based on the method of Schmitz et al . ( 1973 ). The pellet
was homogenized with 10 strokes in 20 ml of Buffer I, an
aliquot for marker enzyme and experimental assays was
removed, and this was followed by the addition of 1 M-MgCl2
to a final concentration of 10 mM, and left on ice for 30
min with occassional stirring. An increase in turbidity was
observed since the addition of MgCl2 causes the aggregation
of basal-lateral membranes, but not brush border membranes,
into large particles which sediment at lower gravitational
forces, probably because of electrostatic interactions
between the cation and membrane surface charges. Basal-
lateral membranes were then obtained by centrifugation at
3,000g (Beckman 50Ti rotor, rav. 5.91 cm) for 15 min, whilst
the brush border membranes were obtained by centrifuging the
resulting supernatant at 35,000g (50Ti rotor) for 30 min.
Both pellets were then washed with 25 ml 1 mM-EDTA to remove
excess Mg2+ ions, pelleted by centrifugation at 35,000g
(Beckman 50.2Ti rotor, rav. 8.12 cm) for 30 min and finally
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resuspended in 80% 1 mM-Hepes, pH 7.5, 0.1 M-D-mannitol,
(Buffer II) / 20% S4. Both of the aliquots removed from the
homogenate and mixed plasma membrane fractions for marker
enzyme assays were also pelleted at 35,000g (50Ti rotor) for
30 min and resuspended in 80% Buffer II / 20% S4. Membranes
were suspended at a concentration of 3-5 mg/ml, quick-frozen
in liquid nitrogen, and stored at -70°C.
2.2.1.2 Determination of protein
Protein was determined by a modification of the method of
Bradford (1976). A stock solution was prepared by
dissolving 100 mg of coomassie brilliant blue G in 50 ml 95%
ethanol and adding 100 ml 85% orthophosphoric acid. 18 ml
of this stock solution was diluted to 100 ml with double-
distilled water, and filtered through Whatman No.l filter
paper.
For protein estimation 0.5 ml of the membrane sample
(containing 10-50 of protein) was added to 2.5 ml of the
diluted Bradford protein reagent and the absorbance at 595
nm measured after 30 min. A standard curve was constructed
using bovine serum albumin as the standard.
2.2.1.3 Marker enzyme assays
In order to determine the purity of the membrane fractions
produced in section 2.2.1.1, marker enzyme assays, detailed
below, were carried out. Table 2-1 summarizes the location
of these enzymes in the cell. No golgi marker enzyme assay
was determined. The linearity of all the assays was
determined using purified commercial enzyme preparations or
freshly prepared mitochondria.
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Sucrase was assayed according to the method of Dahlqvist
(1968). The assay mixture consisted of 28 mM-sucrose,
50 mM-NaH2PO4/Na2HPO4 , pH 6.4, and 0.001-0.020 mg membrane
protein: the diluted enzyme solution should contain less
than 0.01 units/ml of sucrase activity (Dahlqvist, 1968),
where 1 unit is equivalent to 1jumol product produced per
min. The reaction was started by the addition of the
substrate to give a reaction volume of 0.2 ml, and the
mixture was incubated for exactly 60 min at 37°C. The assay
was also performed in the presence of 0.1% (w/v) saponin to
disrupt the membrane vesicles, which might be present both
in the right-side-out and right-side-in orientation, thus
preventing the enzyme from being masked from its substrate.
However, it is generally thought that membranes produced by
divalent cation precipitation techniques are obtained as
right-side-out orientated vesicles (Haase et al., 1978).
All solutions were preincubated for 5 min prior to the
addition of the substrate. The reaction was stopped by the
addition of 50 1 0.5 M-Tris/HCl, pH 7: tris is only one of
a large number of polyalcohols that inhibit disaccharidase
activity (Dahlqvist, 1968). The glucose produced was
quantified with glucose GOD-Perid reagent (Werner et al.,
1970). After centrifuging the samples at 9,000g (rav.
4.62 cm) for 5 min in a MSE Micro Centaur, 20 jXl of the
reaction mixture was added to 1 ml of the Perid reagent, and
the solution incubated for 30 min at 25°C and the absorbance
at 610 nm measured within a further 30 min. A glucose
standard curve was constructed in order to determine the
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quantity of glucose produced.
2.2.1.3.2 (Na+-K+ )ATPase
(Na+-K+)ATPase was assayed by its ouabain-sensitive, K+-
dependent phosphatase activity, according to the method used
by Murer et al. (1976) and adapted by Colas and Maroux
(1980). The assay mixture contained 25 mM-Tris/HCl, pH 7.6,
5 mM-MgS04 , 2.5 mM-EDTA, 45 mM-KCl, 0.05-0.15 mg membrane
protein and 5 mM-p-nitrophenylphosphate (Sigma 104
phosphatase substrate), and was incubated for 30 min at 37°C
in the presence and absence of 1 mM-ouabain. Ouabain was
solubilized prior to adding to the assay mixture by warming
at 37°C in 50 mM-Tris buffer, pH7.6, for 3 hr. The assay
was performed in the presence and absence of 0.1% (w/v)
saponin. The reaction was initiated by the addition of the
p-nitrophenylphosphate to give a reaction volume of 1.2 ml,
and stopped by adding 0.2 ml 3 M-NaOH. All solutions were
preincubated for 5 min prior to the addition of the
substrate, except for the membranes which were preincubated
with the ouabain for 30 min. After centrifuging the samples
at 9,000g (MSE Micro Centaur) for 5 min, the amount of p-
nitrophenol released was determined by measuring the
absorbance at 410 nm (the molar extinction coefficient for
p-nitrophenol is 18300 M-1 at 410 nm). Ouabain-sensitive
K+-phosphatase activity was then determined by subtracting




Alkaline phosphatase activity was determined by the
production of p-nitrophenol from p-nitrophenolphosphate
(Mircheff and Wright, 1976). The assay mixture consisted of
40 mM-Tris/HCl, pH 9.0, 5 mM-MgCl2 , 0.25 mM-CaCl2 , 0.2 mM-
ZnCl2, 0.001-0.040 mg membrane protein and 5 mM-p-nitro-
phenylphosphate, and was incubated for 30 min at 37°C in
both the presence and absence of 0.1% (w/v) saponin. The
reaction was initiated by the addition of the substrate to
give a reaction volume of 1 ml, and stopped by adding 3 ml
lM-NaOH. All solutions were preincubated for 5 min prior to
the addition of the substrate. Samples were centrifuged at
9,000g (MSE Micro Centaur) for 5 min and the amount of p-
nitrophenol produced determined by measuring the absorbance
at 410 nm.
2.2.1.3.4 Acid phosphatase
Acid phosphatase activity was determined by the method of
Michell et a 1. (1970), which involves the production of
p-nitrophenol from p-nitrophenolphosphate. The assay
mixture contained 50 111M-CH3 COONa buffer, pH 5.0, 4 mM-
NaEDTA, 0.001-0.020 mg membrane protein and 10 mM-p-
nitrophenylphosphate, and was incubated for 30 min at 37°C
in both the presence and absence of 0.1% (w/v) saponin.
NaEDTA was added to inhibit alkaline phosphatase, as
suggested by Hiibscher and West (1965). The reaction was
initiated by the addition of the substrate to give a
reaction volume of 1 ml, and stopped by adding 2 ml 0.1 M-
NaOH. All solutions were preincubated for 5 min prior to
-63-
the addition of the substrate. Samples were centrifuged at
9,000g (MSE Micro Centaur) for 5 min and the amount of p-
nitrophenol produced determined by measuring the absorbance
at 410 nm.
2.2.1.3.5 Succinate dehydrogenase
Succinate dehydrogenase activity was measured by the
reduction of 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyl-
tetrazolium hydrochloride (INT) as described by Pennington
(1961), except for two modifications recommended by Porteous
and Clark (1965): the assay was performed in the presence of
2 mM-EDTA and the complete system was kept at 0°C for 30 min
prior to the assay. Porteous and Clark (1965) found that in
the absence of EDTA reaction velocities were proportional to
the amount of enzyme only above a certain minimum amount of
enzyme and that below this quantity no enzymic activity was
detected. However, with EDTA a linear plot of activity
against protein content of the reaction mixture was obtained
and this plot extrapolated to zero activity at zero enzyme
concentration. The assay mixture contained 50 mM-
K2HPO4/KH2PO4, pH 7.4, 50 mM-sodium succinate, 25 mM-
sucrose, 2 mM-EDTA, 0.1% INT and 0.1-0.2 mg membrane
protein, and was incubated for up to 45 min at 37°C in
sealed test-tubes, and in both the presence and absence of
0.1% (w/v) saponin. The reaction volume was 1 ml. All
solutions were preincubated for 5 min at 37°C prior to the
start of the assay. A stock solution of 0.2% INT in lOOmM-
K2HPO4/KH2PO4, pH 7.4, was solubilized prior to the assay by
warming for 3 hr at 37°C. The reaction was started by the
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addition of the INT and stopped by adding 1 ml 10% TCA, and
the formazan produced (the reduced form of INT which is
insoluble in water) was solubilized by adding 4 ml ethyl
acetate. The tubes were shaken vigorously to ensure the
complete solubilization of the formazan, and then left for
30 min to allow the separation of the two phases. Samples
of the ethyl acetate extract containing the formazan were
clarified by the addition of a tenth of a volume of methanol
(Michell et al., 1970) and their absorbances measured at
490 nm (the molar extinction coefficient is 20100 cm2 mol-1 at
490 nm).
2.2.1.3.6 NADPH-cytochrome c reductase
The activity of NADPH-cytochrome c reductase was measured
spectrophotometrically at 37°C in a Philips PU 8700 series
spectrophotometer by following the reduction of cytochrome c
at 550 nm (Sottocasa et al., 1967). The assay mixture
consisted of 6 mM-K2HPCU /KH2P04 , pH 7.4, 3 mM-MgCl2 , 3 mM-
ADP, 130 mM-sucrose, 0.12 mM-NADPH, 0.032 mM-cytochrome c
and 0.1-0.2 mg membrane protein, and was incubated in both
the presence and absence of 0.1% (w/v) saponin. The
reaction was started by the addition of the cytochrome c and
the reaction volume was 1 ml. All solutions were
preincubated for 5 min at 37°C prior to the start of the
assay. The activity of the enzyme was expressed in units of
change in absorbance per min per mg membrane protein.
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2.2.1.4 Electron microscopy
Samples were prepared for ultrathin sectioning as follows.
An aliquot of each membrane fraction (containing about 1 mg
protein) was pelleted by centrifugation at 100,000g (Beckman
70.1Ti rotor, rav. 6.1 cm). Each pellet was then fixed for
1 hr in the first fixative, which consisted of 0.1 M-sodium
cacodylate, pH 7.4, 2% paraformaldehyde, 2.5% glutaraldehyde
and 2 mM-CaCl2 . All procedures were carried out at room
temperature and in a fume cupboard. The pellets were washed
in three changes of 0.1 M-sodium cacodylate, pH 7.4, 2%
paraformaldehyde, 2.5% glutaraldehyde, 2 mM-CaCl2 for a
total of 2 hr and finally fixed again for 1 hr in the second
fixative, which consisted of 0.1 M-sodium cacodylate,
pH 7.4, 1% osmium tetroxide and 2 mM-CaCl2 . The samples
were then dehydrated by placing in the following solutions
in turn; 50%, 70%, 80%, 90%, and 95% ethanol, each for 10
min, followed by three changes of 100% ethanol and two
changes of propylene oxide, each for 15 min. Finally, the
samples were embedded by the following procedure. The
specimens were infiltrated in glass vials with 50% propylene
oxide and 50% araldite mixture (the araldite mixture
consisted of 49% araldite CY212, 49% dodecenyl succinic
anhydride, and 2% benzyldimethylamine) for 30 min on a
rotating holder and then transferred to 100% araldite
mixture and infiltrated in uncapped vials overnight on the
rotator. The next day the samples were infiltrated with
fresh araldite mixture for a further 6 hr on the rotator
before being transferred to dry embedding moulds, filled
with araldite mixture and polymerized for 48 hr at 60°C.
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The polymerized blocks were sectioned, and the thin sections
stained and examined in a Jeol 100S transmission electron




The ADP-ribosylation assay mixture consisted of about 50 (J-g
membrane protein incubated with 20 jag/ml activated toxin
(see section 2.2.2.2), 5 mM-ATP, 0.5 mM-GTP, 200 mM-
K2HPO4/NaH2PO4 buffer, pH 7.5, 10 mM-creatine phosphate,
50 U/ml-creatine phosphokinase, 10 mM-thymidine, 10 mM-
isoniazid, 10 mM-MgCl2 , 2 mM-EDTA and 5 jaM-[adenylate-
32P]NAD+ (25-35 Ci/mmol). Thymidine was added to inhibit
poly ADP-ribosylation, isoniazid to inhibit NAD+-
glycohydrolase activity, and creatine phosphate and creatine
phosphokinase were added as an ATP regenerating system. The
final reaction volume was 100 jj.1. All solutions were
preincubated for 5 min at 30°C and the reaction was started
by the addition of the membranes. The reaction mixture was
incubated for 30 min at 30°C and the reaction stopped by
dilution with 1 ml of ice-cold 10 mM-Mops, pH 7.5, 0.13 M-
NaCl. The reaction mixture was then centrifuged at 9,000g
(MSE Micro Centaur) for 20 min and the supernatant removed
carefully using a syringe. Pellets were solubilized by
boiling for 20 min in 60 jj.1 0.14 M-Tris/HCl, pH 8.8, 25%
(v/v) glycerol, 10% (w/v) SDS, 30 mM-dithiothreitol, 0.01%
(w/v) bromophenol. blue, and analyzed by SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) on a 10% gel (see section
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2.2.2.3). The gel was stained for protein, dried and
autoradiographed using Agfa-Gevaert x-ray film (see section
2.2.2.4). The incorporation of 32P into membrane proteins
was estimated by densitometric analysis (see section
2.2.2.5).
2.2.2.2 Activation of cholera toxin
Cholera toxin was activated prior to use in the ADP-
ribosylation assay. This was to ensure the complete
separation of the Ai from the A2 chain. The activation
buffer used consisted of 10 mM-Mops, pH 7.5, 7 mM-
dithiothreitol, 0.13 M-NaCl, 0.01% (w/v) SDS, 1% (w/v) BSA,
and 190 jx1 of this buffer was incubated with 10 jml 10 mg/ml
cholera toxin for 30 min at 37°C. This gave a final cholera
toxin concentration of 500 jag/ml.
2.2.2.3 Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis was routinely carried out
under denaturing conditions by the addition of 0.1% (w/v)
SDS (SDS-PAGE) to both the stacking and the separating gels.
The gel and buffer system used was based on that of Laemmli
(1970) with the addition of 2 mM-EDTA to chelate any metal
ions which would interfere with the polymerization of the
acrylamide and cause the aggregation of proteins (Douglas
and Butow, 1976). Polyacrylamide of molecular mass up to
5x10® Da was added to 0.4% (w/v) in the separating gel to
increase the mechanical strength. Protein samples were
applied to the gel and electrophoresed at 100 V for one
hour, while the proteins moved into the stacking gel, and
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then at 60 V overnight. Gels were fixed in 20% (v/v)
methanol, 10% (v/v) acetic acid for 15 min, stained in
0.25% (w/v) coomassie brilliant blue R, 45% (v/v) methanol,
9% (v/v) acetic acid for 15 min at 55°C, and destained in
5% methanol, 7.5% acetic acid (v/v) at 55°C until the gel
background was clear. The addition of pieces of polystyrene
foam quickened the destaining process.
For the determination of the molecular masses of membrane
proteins, gels were calibrated with the following standard
proteins: bovine milk cc-lactalbumin (14.2 kDa), soybean
trypsin-inhibitor (20.1 kDa), bovine pancreas trypsinogen
(24 kDa), bovine erythrocyte carbonic anhydrase (29 kDa),
rabbit muscle glyceraldehyde-3-phosphate dehydrogenase
(36 kDa), egg albumin (ovalbumin) (45 kDa), bovine serum
albumin (66 kDa), rabbit muscle phosphorylase b (subunit)
(97.4 kDa), E. coli p-galactosidase (subunit) (116 kDa) and
rabbit muscle myosin (subunit) (205 kDa). These proteins
were supplied as standard kits from Sigma Chemical Co.:
Dalton Mark VII-LTM molecular weight marker kit for the
determination of molecular masses in the range 14.2 to
66 kDa and a high molecular weight standard mixture for




After destaining, the gels were dried using a Bio-Rad model
443 slab gel dryer onto Whatman 3mm filter paper under
vacuum for 1 hr at 80°C. Before drying, gels were covered
with Saran WrapTM, a nonporous plastic film. Once dried,
the Saran Wrap™ was removed and the gels were exposed to
Agfa-Gevaert x-ray film in a Du Pont Cronex cassette
containing 'lightning plus' intensifying screens and left at
-70°C for 2-7 days. Gels were routinely exposed to film for
short and long periods: short periods so that the x-ray film
was not saturated and so could be analyzed densitometric-
ally, and long periods to see if there were any weakly
labelled proteins. Films were developed automatically using
a Fuji RGII x-ray film processor.
2.2.2.5 Densitometric analysis
Both the gels and the autoradiographs were scanned using a
Joyce Loebl Chromoscan 3 densitometer linked to a DCS turbo
(IBM PC clone) computer, keyboard, monitor and Epson LX-80
dot matrix printer. The software used to analyze the data
was a Joyce Loebl Chromoscan 3 External Data Analysis
Package. Gels and autoradiographs were scanned using a 530
nm filter and absorbance signals corresponding to the amount
of protein on gels and of radiolabel on autoradiographs were
converted to arbitrary units from the printout of integrated
values. In a particular experiment the same amount of
protein was present in each assay tube and so the same
amount of protein would be expected to be loaded in each
well of the gel. To check that this was the case, all gel
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tracks were scanned densitometricallv after staining and if
anv of the integrated values obtained for these tracks were
greater than 5% different from each other, then the
corresponding integrated values for the radiolabel on the
autoradiographs were normalized to account for this. The
proportionality of densitometry (i.e. the linear range) was
determined by varying the exposure times and the amounts of
radioactivity exposed to x-ray film.
2.2.3 Adenylate cyclase assay
2.2.3.1 General method
Adenylate cyclase was assayed by a method based on that of
Salomon (1979) by determining the amount of cyclic [32P]AMP
produced from [ot-32P]ATP. The reaction mixture consisted of
40 ^_*.l of assay cocktail, and either (i) 35 /Al membrane
protein (containing 50 jsg protein) in 20 mM-Mops, pH 7.5,
and 25 jjiI 40 mM-sodium fluoride, or (ii) 60 jul membranes
(containing 50 jjg protein) ADP-ribosylated by cholera toxin
as described in section 2.2.2.1 except that the [adenylate-
32P]NAD+ was replaced with 20 mM-NAD+, giving a total
reaction volume of 100 jaI • The assay cocktail consisted of
125 mM-Mops, pH 7.5, 2 mM-ATP, 25 j^M-GTP, 30 mM-creatine
phosphate, 125 U/ml-creatine phosphokinase, 6.25 mM-cyclic
AMP, 2.5 mM-dithiothreitol, 25 mM-MgCl2 , 2.5 U/ml-adenosine
deaminase, 0.25 mM-isobutylmethylxanthine (IBMX), 0.25 mg/ml
BSA and 5-15xl07 cpm/ml [o(.-3 2 P] ATP. Adenosine deaminase was
added to deaminate any adenosine which might be present,
thus preventing it from inactivating adenylate cyclase:
adenosine activates the inhibitory regulatory subunit of
adenylate cyclase. IBMX was added as a phosphodiesterase
inhibitor. All solutions were preincubated for 5 min at
30°C and the reaction was started by the addition of the
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membranes. The membranes that were used for investigating
the effect of sodium fluoride on adenylate cyclase activity
were preincubated for 30 min before using in the adenylate
cyclase assay. This was to ensure that they had been
incubated for the same length of time as those membranes
that were ADP-ribosylated by cholera toxin. The reaction
mixture was incubated for 20 min at 30°C, and the reaction
stopped by adding 25 jxl 0.5 M-HC1 containing about 10,000
cpm cyclic [8-3H]AMP (to determine the recovery in the later
chromatographic step). The tubes were boiled for 2 min, and
immediately placed on ice for 10 min. After neutralizing
the samples with 25 jjlI 1.0 M-imidazole (the pH of the
reaction mixture after the addition of the 0.5 M-HC1 was
about 1.4), 1 ml 0.1 M-imidazole/HCl buffer, pH 7.3, was
added and the samples passed through chromatographic columns
containing 1 g prewashed alumina (see section 2.2.3.2)
according to the method of White (1974), in order to
separate the cyclic [3ZP]AMP from the unreacted [32P]ATP.
The highly charged unreacted [at-3 2 P] ATP binds to the
alumina, whereas the newly formed cyclic\32P1AMP
passes through the columns on the addition of buffer. After
washing the columns with 1 ml 0.1 M-imidazole/HCl buffer,
pH 7.3, and allowing the eluate to completely drain, a
further 2 ml was added and the eluate collected (see section
2.2.3.3) and counted in 14 ml scintillation fluid (see
section 2.2.3.4). Recoveries from the columns were 65-75%
and were calculated by determining the difference between
the number of counts per minute of cyclic [8-3H]AMP loaded
onto the column and the number of counts per minute eluted.
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2.2.3.2 Packing alumina columns
Disposable polystyrene columns (from Pierce) were partially
filled with 0.1 M-imidazole/HCl buffer, pH 7.3, and 1 g dry
neutral alumina was added such that it fell through the
buffer without trapping any air. When the alumina columns
were prepared it was found that the pH of the buffer that
was initially eluted was higher than that of the buffer
itself. Therefore, the columns were washed with buffer
until the pH of the eluate was the same as that of the
buffer. The volume of wash buffer required was found to be
15 ml. The columns were stored filled with 3 ml buffer and
washed with 15 ml buffer prior to use. Each column was used
only once before being washed out and refilled.
2.2.3.3 Determination of elution volumes for ATP and
cyclic AMP
Assay tubes were prepared containing about 4xl06 cpm/tube
[eg-3 2 P] ATP and the volume made up to 100 with double-
distilled water. 25 j^.1 stopping solution (0.5 M-HC1/10,000
cpm cyclic [8-3H]AMP) was added, followed by 25 ul 1 M-
imidazole and 1 ml 0.1 M-imidazole/HCl buffer, pH 7.3. The
tubes were decanted into the columns and the eluate allowed
to drain completely. 1 ml 0.1 M-imidazole/HCl buffer, pH
7.3, was then added to each of the columns and the eluate
collected in vials containing 10 ml scintillation fluid and
counted (see section 2.2.3.4). This last step was repeated
four times. It was found that all of the ATP was retained
in the columns, whereas 65-75% of the cyclic AMP was eluted
by the combined second and third 1 ml of buffer. Therefore,
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it was decided that after decanting the reaction mixtures
into the columns, the columns should be washed with 1 ml of
buffer and allowed to drain, and then a further 2 ml of
buffer should be added and the eluate collected and counted.
2.2.3.4 Liquid scintillation counting
All radioactive samples produced in the adenylate cyclase
assay were counted in 14 ml LKB Optiphase Safe scintillation
fluid. All samples were identical with respect to volumes,
etc., and for each experiment background and standard vials
were also counted. The background vial consisted of 14 ml
scintillation fluid and 2 ml 0.1 M-imidazole/HCl buffer,
pH 7.3. Two standard vials were counted: the 32P standard
vial consisted of 14 ml scintillation fluid, 2 ml 0.1 M-
imidazole/HCl buffer, pH 7.3, and 40 jji1 of a 1:100 dilution
of the assay cocktail; and the 3H standard vial consisted of
14 ml scintillation fluid, 2 ml 0.1 M-imidazole/HCl buffer,
pH 7.3, and 25 jol of the stopping solution (0.5 M-HC1/10,000
cpm cyclic[8-3H]AMP).
2.2.4 Phosphorylation assay
The phosphorylation assay mixture consisted of about 50 j-kg
membrane protein incubated with 20 |J.g/ml activated toxin
(see section 2.2.2.2), 0.5 mM-GTP, 200 mM-K2HP04/NaH2P04
buffer, pH 7.5, 10 mM-thymidine, 10 mM-isoniazid, 10 mM-
MgCl2 , 2 mM-EDTA, 20 mM-NAD+, 50 mM-Mops, pH 7.5, 1 mM-
dithiothreitol, 0.1 mg/ml BSA, 0.1 mM-IBMX, 1 U/ml-
adenosine deaminase, 0.1% (w/v) saponin and 10 julM- ['jj-3 2 P ] ATP
(10-15 Ci/mmol). The final reaction volume was 100 ul. All
-74-
solutions were preincubated for 5 min at 30°C and the
reaction was started by the addition of the membranes. The
reaction mixture was incubated for 1 min at 30°C and the
reaction stopped by adding 1 ml 15% trichloroacetic acid /
45% ethanol. After leaving on ice for 10 min the reaction
mixture was centrifuged at 9,000g (MSE Micro Centaur) for
5 min and the supernatant removed. Pellets were solubilized
by boiling for 30 min in 60 u.1 0.14 M-Tris/HCl, pH 8.8, 25%
(v/v) glycerol, 30 mM-dithiothreitol, 10% (w/v) SDS, 0.01%
(w/v) bromophenol blue, and analyzed by SDS-PAGE on a 10%
gel (see section 2.2.2.3). The gel was stained for protein,
dried and autoradiographed using Agfa-Gevaert x-ray film
(see section 2.2.2.4). The incorporation of 32P into







In order to investigate any differences in the biochemical
processes occurring on the luminal (brush border) and
contraluminal (basal and lateral) sides of the intestinal
epithelial cell it was necessary to separate the brush
border membrane from the basal-lateral membrane. There are
many methods available for the purification of membrane
fractions, including density gradients (Douglas et a1.,
1972; Mircheff and Wright, 1976; Murer et al., 1976;
Yakymyshyn et al., 1982) and divalent cation precipitation
techniques (Schmitz et al . , 1973; Christiansen and Carlsen,
1981; Stieger and Murer, 1983; Aubry et al., 1986). The
problem with these methods is that they generally lead to
the purification of only one or the other of the membrane
fractions, and not of both at the same time. Generally,
when preparing membranes either (i) a crude plasma membrane
fraction is produced from an homogenate of the cells which
is then subjected to two different procedures to yield the
final purified fractions (for example see Colas and Maroux,
1980) or (ii) the final purified membranes are produced
completely independently by different methods, but from the
same homogenized cells (for example see Domfnguez et al.,
1985, 1987; Lazo et al., 1985); in both cases the basal-
lateral membranes might be prepared by using a sorbitol or
sucrose gradient, whereas the brush border membranes might
be prepared by cation precipitation. Different procedures
employed in the isolation of luminal and contraluminal
plasma membranes make it difficult to evaluate whether the
enzyme has been preferentially inactivated by one of them,
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even if the length of the isolation procedure is the same.
This is obviously disadvantageous since it is then hard to
compare activities of marker enzymes and so the results of
any biochemical experiments on the two fractions will be
hard to interpret. Due to this difficulty it appears that
many workers have concentrated on the preparation and
characterization of either basal-lateral membranes (Douglas
et al . , 1972; Mircheff et al., 1979) or brush border
membranes (Schmitz et al., 1973; Kessler et al., 1978;
Hauser et al . , 1980; Stieger and Murer, 1983).
Another problem with these methods is the time taken in the
purification procedures. Many workers use procedures for
preparing say, basal-lateral membranes by density gradient
centrifigation taking up to 24 hr, and yet produce brush
border membranes by a different procedure taking only a
couple of hours. This means that there will be considerably
more inactivation of enzymes in one purified fraction
compared to the other, again making comparisons of enzymic
activities meaningless. Some workers have tried to get
around this problem by using differential centrifugation to
produce two pellets, one containing brush border membranes
and one containing basal-lateral membranes, and then
purifying them by using the same density gradient procedure
for both (Mircheff and Wright, 1976). However, the 24 hr
spin used by Mircheff and Wright (1976) may still result in
the inactivation of enzymes particularly the enzyme of
interest, adenylate cyclase, which is very labile (Parkinson
et al., 1972).
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The technique of cation precipitation, introduced by Schmitz
et al. (1973), is a simple and rapid technique which is
commonly used by many workers. However, this
procedure seems to be good only for preparing purified brush
border membranes (Schmitz et al., 1973; Hauser et al., 1980;
Christiansen and Carlsen, 1981; Stieger and Murer, 1983;
Aubry et al., 1986). The reason for this appears to be that
the brush border membranes are prepared from a crude plasma
membrane preparation also containing basal-lateral
membranes, mitochondria, nuclei, Golgi apparatus membranes
and microsomes. When the divalent cation is added all the
membranes, except the brush border membrane fragments,
aggregate into large particles which can be sedimented at a
low gravitational force: the aggregation is probably due to
electrostatic interactions between the cation and membrane
surface charges. The failure of brush border membranes to
aggregate probably indicates that, despite the negatively-
charged glycocalyx (Ito, 1969), the brush border membrane
surface, at or near neutrality, is more positively charged
than the microsomal, mitochondrial and basal-lateral
membrane surfaces. This means that although the brush
border fraction is relatively pure, the basal-lateral
fraction is contaminated with fragments of cell organelles.
This problem could be resolved by subjecting the membranes
to a series of centrifugation steps to remove any
contaminating membranes before precipitating with the
cation. The three methods of divalent cation precipitation
that have been used are (i) Ca2 + , (ii) Mg2 + , and (iii)
Mg2+/EGTA. There have been many diverse reports on which is
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the best method for precipitating membranes. Aubry et al.
(1986) compared the procedures involving Ca2 + and Mg2+
precipitation by analyzing the marker enzyme content and
lipid composition of the membranes to establish which method
yielded the purest and most structurally intact fractions.
They came to the conclusion that Ca2 + prepared membranes
were less contaminated by basal-lateral membranes than were
Mg2 + prepared membranes and that the use of Ca2 + did not
notably enhance the degradation of endogenous lipids by
brush-border membrane phospholipase A. Hauser et al. (1980)
recommended using EGTA and Mg2+ instead of Ca2 + to aggregate
contaminating membranes. They found that membranes prepared
using Ca2+ had exceptionally high levels of lipid
decomposition, and that this was dramatically reduced by
using EGTA to keep the free Ca2+ concentration low so that
the intrinsic Ca2♦-activated phospholipase A was
inactivated. Stieger and Murer (1983), however, have found
that brush border membrane vesicles prepared by the
Mg2+/EGTA method are not homogeneous. This could be because
(i) the Mg2+ precipitation step does not remove all the
basal-lateral membranes, (ii) vesicles are formed during the
homogenization, which consist of both brush border and
basal-lateral elements, or (iii) since the mucosa is scraped
with a glass slide there may be cells of different types and
stages of differentiation present during the homogenization:
membranes of undifferentiated cells have different enzymic
patterns to those derived from the tip of the villi (Weiser,
1973 ) .
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Thus, although the method of Ca2 + precipitation may produce
a purer brush border membrane fraction, it may cause the
activation of adenylate cyclase or increase the
phosphorylation of membrane proteins, rendering it
impossible to distinguish the effects due solely to cholera
toxin from those due to Ca2+ . Therefore, the best cation
precipitation method would seem to be that involving the use
of Mg2+ , as used by Christiansen and Carlsen (1981), rather
than Ca2 + . Christiansen and Carlsen (1981) estimated that
they got a minor contamination of brush border membranes
with basal-lateral membranes of approximately 10%.
3.2 Preparation of rat intestinal membrane fractions
3.2.1 Method
Three male Sprague-Dawley rats were sacrificed by cervical
dislocation and the mixed plasma, brush border and basal-
lateral membrane fractions prepared by following the
procedure outlined in section 2.2.1.1 and Figure 2-1.
3.2.2 Marker enzyme assays and determination of protein
Protein was determined as in section 2.2.1.2 according to
the method of Bradford (1976). Three marker enzyme assays
were carried out to determine the purity of the fractions
produced. These were sucrase (see section 2.2.1.3.1),
alkaline phosphatase (see section 2.2.1.3.3) and (Na+-K+ )-
ATPase (see section 2.2.1.3.2). All of the marker enzyme
assays were carried out as detailed in the indicated
sections, except that they were performed only in the
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absence of the detergent saponin.
3.2.3 Electron microscopy of membrane fractions
Samples of homogenate, mixed plasma membranes, brush border
membranes and basal-lateral membranes were analyzed and
compared by electron microscopy as outlined in section
2.2.1.4.
3.2.4 Activation of adenylate cyclase
The activation of adenylate cyclase by sodium fluoride was
determined as in section 2.2.3.1. For details of the
calculation involved in determining the amount of cyclic AMP
produced see Appendix C.
3.2.5 Results and discussion
The results of the marker enzyme assays, shown in Table 3-1,
indicate that there was some separation of the membranes.
Sucrase, a marker enzyme for the brush border membrane, had
an activity 5.1-fold greater in brush border than in basal-
lateral membranes; on the other hand alkaline phosphatase
activity was 3.4-fold greater in brush borders. This lower
value for alkaline phosphatase may reflect the result
obtained by other workers (Mircheff and Wright, 1976), which
is that the enzyme appears to be located in both membranes,
although to a greater extent in brush borders.
(Na+-K+)ATPase, a marker enzyme for basal-lateral membranes,
had an activity that was 2.5-fold greater in basal-lateral
membranes than in brush border membranes.
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Figure 3-1 (A-E) shows the appearance of whole cells (A and
B), mixed plasma membranes (C), brush border membranes (D)
and basal-lateral membranes (E) under the electron
microscope. The micrographs of the whole cell fraction
clearly show recognizable structures, such as mitochondria
(A) and nuclei (B), which appear to be absent from the other
three fractions. However, the mixed plasma membrane (C) and
basal-lateral membrane (E) fractions contain electron-dense
material, some of which might be the result of contamination
by nuclear or some kind of fibrous material. Although the
marker enzyme assays (Table 3-1) show only a relatively
small degree of separation compared to other workers
(Douglas et al . , 1972; Christiansen and Carlsen, 1981;
Dominguez et al., 1985), the brush border membrane (D) and
basal-lateral membrane (E) fractions do look quite different
under the electron microscope; although, both fractions
consist of vesicles and membranous sheets. Therefore, prior
to improving the separation procedure it was decided to try
and assay for adenylate cyclase activity in the mixed
plasma, basal-lateral and brush border membrane fractions.
If cholera toxin was used as the activator of the enzyme and
the assay yielded no result, it would be difficult to
determine whether it was the adenylate cyclase assay or the
ADP-ribosylation assay that was responsible: the ADP-
ribosylation of the membrane proteins is necessary before
they can be used in the adenylate cyclase assay. Therefore,
it was decided to use sodium fluoride as the activator since
this only involves one assay. However, using sodium
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Fig. 3-1 Electron micrographs of rat intestinal membrane
fractions
Whole cells (A and B), mixed plasma membranes
(C), brush border membranes (D) and basal-lateral
membranes (E) were prepared for examination under
the electron microscope as outlined in section






Fig. 3-1 Electron micrographs of rat intestinal membrane
fractions
Whole cells (A and B), mixed plasma membranes
(C), brush border membranes (D) and basal-lateral
membranes (E) were prepared for examination under
the electron microscope as outlined in section
2.2.1.4. Magnification x 30,000.
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fluoride, no activation of adenylate cyclase was achieved in
any of the three membrane fractions, when compared to the
basal values: all values were less than 1 pmol cyclic AMP
produced per min per mg membrane protein. This experiment
was repeated a number of times and the same result was
obtained. This lack of activation could have been due
either to the inactivation of the cyclase during the
preparation of the membranes, or because of the conditions
or the components of the assay itself. In order to discount
this latter reason membranes were required that were very
rich in adenylate cyclase activity: such membranes were
those of pigeon red blood cells (van Heyningen, 1977b).
35^1 0.3% pigeon red blood cells in 20 mM-Mops, pH 7.5,
were incubated with 25 ^jil 40 mM-sodium fluoride and 40 yl of
assay cocktail for 20 min at 30°C as outlined in section
2.2.3.1. The effect of sodium fluoride on adenylate cyclase
activity in mixed plasma membranes was also investigated at
the same time to compare activities. With the mixed plasma
membranes there was still no activation, whereas with the
blood cells 384 pmol cyclic AMP was produced per min per ml
blood, compared to a basal level of 4 pmol per min per ml.
This result therefore implies that the assay conditions were
satisfactory and that maybe the cyclase was inactivated
during the preparation of the rat intestinal membrane
fractions. Other possibilities were that the activity of
the cyclase is naturally low in rat intestinal cells and so
was easily lost during the membrane preparation, or that
maybe the phosphodiesterase activity is higher in these
cells. After repeating the assay a few times, changing the
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experimental conditions, for example lowering the incubation
temperature to 25°C, using a different phosphodiesterase
inhibitor (i.e. theophylline), trying fresh membrane
preparations, increasing the ATP concentration, and still
getting the same result, it was decided to try a different
animal model - RABBIT.
3.3 Preparation of rabbit intestinal membrane fractions
3.3.1 Method
One female white New Zealand rabbit was sacrificed by
cervical dislocation and the membrane fractions prepared
from the intestinal epithelial cells as outlined in section
2.2.1.1 and Figure 2-1.
3.3.2 Marker enzyme assays and determination of protein
Protein was determined as in section 2.2.1.2 according to
the method of Bradford (1976). Six marker enzyme assays
were carried out to determine the purity of the fractions
produced. These were sucrase (see section 2.2.1.3.1),
alkaline phosphatase (see section 2.2.1.3.3), (Na+-K+ )ATPase
(see section 2.2.1.3.2), acid phosphatase (see section
2.2.1.3.4), succinate dehydrogenase (see section 2.2.1.3.5)
and NADPH-cytochrome c reductase (see section 2.2.1.3.6).
3.3.3 Protein profiles of membrane fractions
The proteins present in each of the membrane fractions
(mixed plasma, brush border and basal-lateral) were compared
by subjecting 50 ug protein samples to SDS-PAGE on a 10%
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gel, as in section 2.2.2.3. The protein samples were
solubilized prior to applying to the gel by boiling for
20 min in 60 jjd 0.14 M-Tris/HCl, pH 8.8, 25% (v/v) glycerol,
10% (w/v) SDS, 30 mM-dithiothreitol, 0.01% (w/v) bromophenol
blue .
3.3.4 Activation of adenylate cyclase
The activation of adenylate cyclase by both cholera toxin
and sodium fluoride was determined as in section 2.2.3.1.
For details of the calculation involved in determining the
amount of cyclic AMP produced see Appendix C.
3.3.5 Results and discussion
The results of the marker enzyme assays are shown in Table
3-2. Several putative plasma membrane enzymes were enriched
in the membrane fractions, namely sucrase, alkaline
phosphatase and (Na+-K+)ATPase, although the (Na+-K+)ATPase
was not enriched to as great an extent as the other two.
About 25% of the total sucrase and 20% of the total alkaline
phosphatase present in the homogenate was found in the mixed
plasma membrane fraction, whereas only 15% was found in the
case of (Na+-K+)ATPase. After separating a brush border
membrane fraction and a basal-lateral membrane fraction from
the mixed plasma membranes by cation precipitation, the
activity of sucrase was 18.4-fold greater in the brush
border membranes than in the basal-lateral membranes, while
alkaline phosphatase had a 8.4-fold greater activity. It is
not likely that the increase in activity in basal-lateral
membranes and the decrease in activity in brush border
-91-






















































































membranes relative to mixed plasma membranes, for alkaline
phosphatase compared to sucrase, is only a result of
contamination in the basal-lateral membrane fraction by
brush borders. If this was the case, then the same increase
in activity in brush borders compared to basal-lateral
membranes would be expected for alkaline phosphatase as with
sucrase. Instead, this lower enrichment factor is more
likely due to alkaline phosphatase being present in both
membranes, in agreement with the results of other workers
(Mircheff and Wright, 1976). In contrast to the good
separation obtained for brush border membranes, as indicated
by the 18.4-fold greater activity of sucrase in this
membrane fraction compared to the basal-lateral membrane
fraction, the activity of (Na+-K+)ATPase was only 2.8-fold
higher in the basal-lateral membrane fraction than in the
brush border membrane fraction. This low enrichment factor
could be due to basal-lateral membranes being distributed
heterogeneously between the two fractions when the method of
Mgz+ precipitation is used, as was found by other workers
(Stieger and Murer, 1983; Aubry et al., 1986); it could be
due to to crosscontamination by membranes other than those
from the cell envelopment; it may be due to epithelial cells
that have not yet fully differentiated; or it could be a
combination of any of these. It should be stressed at this
point that the measured ouabain-sensitive K+-phosphatase
activity exhibited by (Na+-K+)ATPase gave rather variable
results, probably because of the high activity of other
phosphatases present in the fractions which may interfere
with the assay: all the phosphatase assays were based on the
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same method and the greatest phosphatase activity, expressed
by alkaline phosphatase, was inhibited by the addition of
EDTA to the assay mixture (Hiibscher and West, 1965).
Generally though, the relative specific activities were the
same even if the specific activities differed by a factor of
two, although it was the values for the homogenate that were
the most variable.
The distribution of mitochondria, lysosomes and smooth
endoplasmic reticulum was measured by determining the
activities of succinate dehydrogenase, acid phosphatase and
NADPH-cytochrome c reductase respectively, in the three
fractions. The specific activity of the mitochondrial
enzyme was decreased in the mixed plasma membrane fraction
compared to the homogenate, while the activities of the
lysosomal and smooth endoplasmic reticulum enzymes were
unchanged. The reduced mitochondrial activity of the mixed
plasma membrane fraction compared to the homogenate was
found to be mainly associated with the basal-lateral
membrane fraction after precipitation with MgCl2 : there was
a 8.9-fold greater activity in basal-lateral membranes
compared to brush border membranes. Smooth endoplasmic
reticulum has historically presented the most difficult
problem during the purification of plasma membranes in that
it seems to associate preferentially with basal-lateral
membranes and is very difficult to remove (Mircheff and
Wright, 1976). This accounts for the unchanged specific
activity in mixed plasma membranes compared to the
homogenate, and the subsequent 2.4-fold increase in specific
-94-
activity in basal-lateral membranes compared to brush border
membranes. Acid phosphatase, on the other hand, was found
to have a 1.7-fold greater specific activity in brush border
membranes compared to basal-lateral membranes, as well as
the specific activity of mixed plasma membranes being
unchanged compared to the homogenate. This is in contrast
to other workers (Mircheff and Wright, 1976; Murer et al.,
1976) who have found a decrease in specific activity in
mixed plasma membranes compared to the homogenate, as well
as a preferential association of any contaminating lysosomal
membranes with basal-lateral membranes.
As mentioned in Chapter Two, all the marker enzyme assays
were performed in both the presence and absence of saponin
to ensure that all the enzyme active sites were available
for interaction with the substrate, even though it has been
reported by Haase et al . (1978) that membranes prepared by
the method of cation precipitation are obtained as right-
side-out orientated vesicles. Kessler et al. (1978)
reported that sucrase was present on the luminal side of
prepared brush border membrane vesicles and suggested that
these vesicles were orientated luminal-side-out (i.e. right-
side-out). However, some workers (Christiansen and Carlsen,
1981; Yakymyshyn et al., 1982) have found that the majority
of the vesicles produced in their brush border membrane
preparations were open-ended, thus making it difficult to
prove the exclusive luminal-side-out orientation of
vesicles. Yakymyshyn et al. (1982) found that the activity
of alkaline phosphatase increased 3-fold after sonication,
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whereas with sucrase no difference was observed. Their
conclusion was that this suggested alkaline phosphatase to
be located on the inner and outer vesicle surfaces unlike
sucrase which was totally confined to the outer membrane
surface. These results support the theory that brush border
membrane vesicles are exclusively orientated right-side-out,
since if this was not the case then sucrase activity would
be expected to increase in the same way as that of alkaline
phosphatase. In the case of this study no increase in
activity was observed with any of the marker enzymes in the
presence of saponin, except for alkaline phosphatase, in
agreement with Yakymyshyn et al. (1982), where the specific
activity of each fraction increased 1.5-fold, but still
gave the same relative specific activity values. All the
values quoted in Table 3-2 are those found in the absence of
saponin, although there was not a lot of difference between
these values and those found in the presence of saponin.
These marker enzyme assay results therefore show that there
has been a good membrane separation as far as brush border
membranes are concerned, and that the low specific activity
of (Na+-K+)ATPase in basal-lateral membranes was probably
due to a combination (1) of contamination by intracellular
organelles that have not been fully removed prior to the
addition of MgCl2 and so are aggregated with the basal-
lateral membranes, and (2) of not all the basal-lateral
membranes being aggregated by the addition of the MgCl2 in
the cation precipitation stage. The protein profiles of
each of the three membrane fractions (mixed plasma, brush
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border and basal-lateral) on a 10% polyacrylamide gel are
shown in Figure 3-2, and show that the brush border and
basal-lateral membrane proteins are completely different
from each other, whereas the mixed plasma membrane fraction
contains proteins from both. Particularly striking are the
three protein bands isomaltase, sucrase and actin, which are
present to a much greater extent in the brush border
membrane fraction and are according to Tiruppathi et al .
(1986) proteins only present in the brush border membrane.
Therefore, having achieved as good a separation of the
membrane fractions as other workers who have used the same
method of cation precipitation with MgCl2 (Christiansen and
Carlsen, 1981; Aubry et al., 1986), or even as those who
have used other methods (Murer et al., 1976; Domfnguez
et al., 1985), it was decided to test these membranes for
adenylate cyclase activity.
When sodium fluoride was used as the effector molecule there
was an activation of adenylate cyclase in the mixed plasma
membrane fraction from a basal level of less than 1 pmol
cyclic AMP produced per min per mg membrane protein to 60
pmol per min per mg protein. With cholera toxin the
activity of adenylate cyclase was found to be 14 pmol per
min per mg protein. Therefore, having achieved a good
separation of brush border membranes from basal-lateral
membranes, and getting an activation of adenylate cyclase by
both cholera toxin and sodium fluoride in these fractions,
it was decided to investigate the ADP-ribosylation and













Fig. 3-2 Protein profiles of the membrane fractions
A, B and C show the protein profiles of mixed
plasma membranes, brush border membranes and
basal-lateral membranes respectively on a 10%
polyacrylamide gel. The membranes were prepared
from rabbit intestinal epithelial cells as
outlined in section 2.2.1. The migration of
molecular mass standards expressed in kDa is as
indicated.
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activation of adenylate cyclase in these fractions in
detail. The ADP-ribosylation and adenylate cyclase assays
described in Chapters Four and Five are based on the same
membrane preparation, the marker enzyme assay results of
which are shown in Table 3-2, whereas the phosphorylation
assay results of Chapter Six are based on a different
membrane preparation, but one which has very similar marker






After separating the brush border and basal-lateral
membranes from a mixed plasma membrane fraction, the ADP-
ribosylation of membrane proteins within each of these
fractions was investigated. Domfnguez et al. (1985, 1987)
and Lazo et al. (1985) showed that cholera toxin catalyzed
the ADP-ribosylation of three membrane proteins of molecular
mass 40, 45, and 47 kDa in brush border membranes of rabbit
intestinal epithelial cells. However, they found no similar
effects with basal-lateral membrane proteins and so came to
the conclusion that the regulatory component of adenylate
cyclase, Gs , was present only in brush border membranes.
Although their conclusions appear reasonable, it seems very
strange that they did not get any ADP-ribosylation of
proteins in the basal-lateral membrane fraction since the
marker enzyme results of their membrane purification, which
are very similar to results obtained in this study (see
Table 3-2), quite clearly show some crosscontamination with
brush border membrane proteins. Therefore, in this project,
the proteins labelled in each membrane fraction (mixed
plasma, brush border and basal-lateral membranes) were
initially identified. The incorporation of 32P-ADP-ribose
into each membrane protein in each membrane fraction was
then determined and compared to the relative specific
activities of the marker enzymes.
If the Gs protein is located only in the brush border
membrane, then the problem is how it gets to the catalytic
component of adenylate cyclase, which is reported to be
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located on the basal-lateral membrane (Murer et al., 1976;
Walling et al., 1978). In 1985 Rodbell proposed a theory
which could account for this problem. He depicted the oC.
subunits of the GTP-binding regulatory proteins as being
'programmable messengers' which are released from the plasma
membrane when exposed to activating agents such as hormones,
F", Mg2+ or GTP, and bacterial toxins such as cholera toxin.
He further proposed that once free these eg subunits would be
able to interact with other components of the cell and/or
plasma membrane. This would then imply that the p and/or y
subunits would behave as moorings for the attachment of the
egsubunits. Indeed, the work of Sternweis (1986), which
shows that the eg subunits cannot associate with plasma
membranes in the absence of subunits, supports Rodbell's
hypothesis. Evidence has also been provided showing that
the ADP-ribosylation of the eg subunit of Gs causes its
release from rat liver plasma membranes (Lynch et al.,
1986). Therefore, in this project an experiment was
conducted to try and demonstrate that, upon activation with
cholera toxin, there is a release of the major ADP-
ribosylated protein from rabbit intestinal brush border
membranes.
The effects of six drugs, with differing anticalmodulin and
antidiarrhoeal activities, were tested for their ability to
inhibit the ADP-ribosylation of membrane proteins: as
mentioned in section 1.4.4, the anticalmodulin activities
refer to the abilities of the drugs to inhibit the
calmodulin-induced activation of phosphodiesterase in vitro
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(Prozialeck and Weiss, 1982). Five of the drugs tested,
namely chlorpromazine (an antipsychotic), trifluoperazine
(an antipsychotic), triflupromazine (an antipsychotic),
promethazine (an antihistaminic) and promazine (a
tranquilizer), belong to the class known as phenothiazines,
while the other drug, amitriptyline (an antidepressant),
belongs to the class known as dibenzazepines. The
structures of these drugs as well as their abilities to
inhibit calmodulin activity, expressed as IC50 values, are
shown in Figure 4-1. These IC50 values for the inhibition
of calmodulin (Prozialeck and Weiss, 1982; Weiss et al.,
1982; Zavecz et al., 1982) (Fig. 4-1) correlate very well
with their abilities to inhibit the diarrhoea induced by
cholera toxin and other agents, such as prostaglandins and
vasoactive intestinal peptide (Ilundain and Naftalin, 1979;
Sandhu et al., 1979; Smith and Field, 1980; Lonnroth et al . ,
1980; Zavecz et al . , 1982); chlorpromazine, trifluoperazine
and triflupromazine have a greater antidiarrhoeal activity
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Fig. 4-1 Structures and anticalmodulin activities of the
antidiarrhoeal drugs
The six drugs tested belong to the phenothiazine
class (A) and the dibenzazepine class (B). ICs0
values for the inhibition of calmodulin were
taken from Prozialeck and Weiss (1982), Weiss et
al . (1982) and Zavecz et al. (1982).
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4.2 ADP-ribosylation of membrane proteins
4.2.1 Method
5 juM- [ Adenylate-3 2 P]NAD+ and 20 jj.g/ml preactivated cholera
toxin were incubated with 50 jxg of either mixed plasma,
brush border or basal-lateral membranes at 30°C for 0-60
min, as outlined in section 2.2.2.1, to look at the
incorporation of 32P-ADP-ribose into the membrane proteins
of each fraction.
4.2.2 Results and discussion
Autoradiographic profiles and graphs from the densitometric
analysis of these autoradiographs are shown in Figures 4-2
and 4-3 respectively. Three proteins of molecular mass 45,
40 and 37 kDa from the mixed plasma membrane fraction were
labelled (Fig. 4-2A). There were also a number of other
weakly labelled proteins (Fig. 4-2). Cholera toxin was also
found to catalyze the labelling of these same proteins in
both the brush border and basal-lateral membrane fractions
(Fig. 4-2B and C). In the absence of cholera toxin no
labelling was observed. Figure 4-3 shows that the
incorporation of 32P-ADP-ribose, under the conditions of
this assay, reached a maximum after about 30 min for each of
the three proteins in each of the three fractions. This
could be because all the G proteins have been labelled, i.e.
fully saturated, or, more likely, because the [adenylate-
32P]NAD+ in the assay mixture has been depleted by NAD+-
glycohydrolase (also known as NADase). This membrane-bound
ectoenzyme is particularly abundant on the surface of
macrophages (Artman and Seeley, 1978) and is therefore very
-105-
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Fig. 4-2 ADP-ribosylation of rabbit intestinal epithelial
cell membranes.
A, B and C show autoradiographic profiles of
mixed plasma membrane proteins, brush border
membrane proteins and basal-lateral membrane
proteins respectively, when incubated with
20 jag/ml preactivated cholera toxin and 5 ^i.M-
[adenylate-32P]NAD+ for 0 min (lane 2), 5 min
(lane 3), 15 min (lane 4), 30 min (lane 5),
45 min (lane 6) and 60 min (lane 7) at 30°C as
in section 4.2.1. The corresponding protein
profiles of mixed plasma membranes, brush
border membranes and basal-lateral membranes,
which were run on a 10% polyacrylamide gel,
are shown in lanes 1A, IB and 1C respectively
(50 jjig membrane protein per lane). Migration



































Fig. 4-3 Time courses for the ADP-ribosylation of membrane
proteins.
Graphs show the incorporation of 32P-ADP-ribose
into 45 kDa (A), 40 kDa (B) and 37 kDa (C)
proteins of mixed plasma membranes (Q—Q)> brush
border membranes (■—■) and basal-lateral
membranes (. Membranes were incubated with
20 ug/ml preactivated cholera toxin and 5 jjiM-
[adenylate-32P]NAD+ at 30°C as in section 4.2.1.
The arbitrary units shown were based on the
integrated values (arbitrary units x 104) obtained
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active in macrophage-!-ich organs such as spleen, lymph
nodes, brain and gut. For a 5% (v/v) suspension of calf
brain membranes (2 mg/ml protein) the half life of 10 jxM
NAD+ at 37°C has been found to be about 10 s (Gill and
Coburn, 1988). This problem of NAD+ hydrolysis can be
alleviated by adding the antituberculous drug isonicotinic
acid hydrazide (also known as isoniazid) to inhibit the
NADase activity. However, isoniazid does not completely
inhibit NADase activity (Kawai et al., 1986; Gill and
Coburn, 1988) and so it is inevitable that the [adenylate-
32P]NAD+ will be hydrolyzed before all the G proteins are
labelled. To check that this was indeed the case the above
experiment was repeated, but for incubation times of 0, 5,
15, 30, 40, 50 and 60 min. After a period of 30 min, extra
[adenylate-32P]NAD+ , GTP and ATP (at the same concentrations
as at the start of the incubation) was added to those
membranes that were being incubated for 40, 50 and 60 min.
The results of this experiment, shown in Figure 4-4, show
that there was an increase in the incorporation of 32P-ADP-
ribose into the 45 and 40 kDa proteins after the addition of
the extra substrate and activators. However, there was no
increase in the labelling of the 45 kDa protein in the
basal-lateral membrane fraction. This must have been due to
some experimental artefact, since the labelling of this same
protein increased in the mixed plasma and brush border
membranes, and so would be expected to increase in the
basal-lateral membrane as well. There was no labelling of
the 37 kDa protein in this experiment and this was also
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Fig. 4-4 Effect of adding extra substrate on the
ADP-ribosylation of membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
(the units shown are the integrated values from
the densitometric analysis of the autoradiographs
into 45 kDa (A) and 40 kDa (B) proteins of mixed
plasma membranes (Q—D)» brush border membranes
(Wk—W^) and basal-lateral membranes ( —JL) •
Membranes were incubated as in section 4.2.1, and
extra [adenylate-32P]NAD+, GTP and ATP were added
after incubating for 30 min (see section 4.2.2).
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due to a slight alteration in the experimental conditions
which caused a reduction in the ADP-ribosylation of this
protein, which at its best was quite weak. However, the
general trend of an increase in labelling after the addition
of more substrate and activators implies that the plateau
observed in Figure 4-3 was due to the depletion of the
substrate and not the saturation of the G proteins with
label.
It is difficult to be certain as to what extent the ADP-
ribosylation of proteins is a property of a particular
membrane fraction because of membrane crosscontamination.
It does not matter how good the membrane isolation procedure
is, it is inevitable that during the separation of a
particular membrane fraction from a mixture of other
cellular organelle membrane fractions there will be some
crosscontamination. The labelling of the 45, 40 and 37 kDa
proteins in each fraction was compared (Table 4-1) by
reading off values from Figure 4-3 corresponding to an
incubation time of 5 min: these values represent the
integrated values obtained from the densitometric analysis
of the autoradiographs shown in Figure 4-2 and drawn
graphically in Figure 4-3. The incubation time of 5 min was
chosen as the point of reference because this represented a
period before the depletion of the substrate, i.e. the
linear portion of the time courses shown in Figure 4-3.
Table 4-1 shows that the incorporation of 32P-ADP-ribose
into the 40 kDa protein of the brush border membrane
fraction was 18-fold greater than in the basal-lateral
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Table4-1Incorporationf32P-ADP-riboseintmem raneprotei s Theexperimentald tailsoftADP-ribosylationayreins c ion4.2.1. Incubationwasfor5m t30"C.Ine chofther emembranefractionsw1sho sth incorporationf32P-ADP-ribose(integratedv lu sobtai dfr mFig r4 3),wsho s valuesre ativetohlabellingft40kDaprot ininth tm mbranedw3sho s valuesre ativetohlabellingft sameprot ininthmix dpla mam brane fraction.Therelativevaluesrepr s ntt meantSDft eexperim nts. FractionRow45kDapr tein0protein37kDaprotein Mixed1240040009 Plasma20.62-0.061.0.22- .04 Membrane31.0.1.0 Brush160004500042 Border20.4*0.041.0.12- .01 Membrane36.72-0.51.32-0.54.72-0.3 Basal-150026 Lateral20.62-0.021.0.22. .01 Membrane30.610.040.6*0.040.71 .07
membrane fraction. This can be compared with the smaller
increase in incorporation for the 45 and 37 kDa proteins of
10.7- and 7-fold respectively, in brush border membranes
relative to basal-lateral membranes. The larger
incorporation of 32P-ADP-ribose into the 40 kDa protein of
brush border membranes relative to mixed plasma membranes
after an incubation time of 5 min is responsible for the
larger 18-fold greater increase in labelling in brush border
membranes compared to basal-lateral membranes. It was a
possibility that this larger incorporation of 32P-ADP-ribose
in brush border membranes was simply due to an experimental
error or artefact, and that the true incorporation was much
lower, thus decreasing the value relative to mixed plasma
membranes of 11.3 to nearer those for the 45 and 37 kDa
proteins of 6.7 and 4.7 respectively. However, the
experiment was repeated a further two times and the same
initial large increase in labelling in the 40 kDa protein of
the brush border membrane fraction was observed, giving an
overall profile very similar to that shown in Table 4-1.
These results may be indicative of a small percentage of the
45 kDa protein, which is the same size as the regulatory
component of other adenylate cyclases (for a general review
see Enomoto and Gill, 1983) being located in the basal-
lateral membrane fraction. On the other hand, the major
protein labelled in each fraction was the one of 40 kDa
(Table 4-1 and Fig. 4-3) and indeed this protein may be Gs<*
since the molecular mass of Gs« in intestinal cells has not
been determined. If this is the case then the 18-fold
greater amount of labelling of this 40 kDa protein in the
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brush border as opposed to the basal-lateral membrane
fraction is comparable to the enrichment of sucrase in these
membranes (about 18.4-fold greater in brush border compared
to basal-lateral membranes) (Table 3-2). This would then
suggest that the ADP-ribosylation of proteins in the basal-
lateral membrane fraction was solely due to contamination
with brush border membrane proteins. However, if the 45 kDa
protein was Gs<* then it would seem that the regulatory
component is present on both membranes, although to a much
greater extent on brush border membranes. Until the
identities and relationships of these proteins are known
this problem of the location of Gs<* cannot be resolved (see
Chapter Seven).
4. 3 Evidence for the release of the o( subunit of Gs upon
ADP-ribosylation
4.3.1 Method
5 juM- [Adenylate-3 2 P]NAD+ and 20 jug/ml cholera toxin were
incubated, as in section 2.2.2.1, with 1.5 mg brush border
membrane protein in a final reaction volume of 1 ml at 30°C
for 20 min. Following this period a 50 jo.1 aliquot was
removed (for the determination of total labelling), added to
60 fsl 0.14 M-Tris/HCl, pH 8.8, 25% (v/v) glycerol, 10% (w/v)
SDS, 30 mM-dithiothreitol, 0.01% (w/v) bromophenol blue
(dissociation buffer), and boiled for 20 min. 400 jjlI of the
remaining ADP-ribosylation assay mixture was treated as in
section 2.2.2.1 (for the determination of soluble labelled
proteins), i.e. transferred to an Eppendorf tube and
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centrifuged at 9,000g (rav. 4.62 cm) in a MSE Micro Centaur
for 20 min. 50 of the resulting supernatant was then
boiled for 20 min in 60 pi dissociation buffer, whereas the
pellet was resuspended using a syringe in 400 pi of membrane
isolation Buffer II (see section 2.2.1.1) and 50 pi of this
mixture was then also boiled in 60 pi dissociation buffer
for 20 min. To ensure that all the membranes were pelleted
by centrifuging the ADP-ribosylation assay sample at 9,000g
(MSE Micro Centaur), leaving only soluble proteins in the
resulting supernatant, a further 400 pi of the assay mixture
was treated as above but with the exception that the
membranes were pelleted by centrifuging at 100,000g in a
Beckman TL-100 centrifuge (TLA-100.3 rotor, rav. 3.17 cm)
for 40 min at 4°C. 50 pi samples, each containing 30 pg
protein, of each of the five boiled mixtures were then
analyzed by SDS-PAGE (see section 2.2.2.3) on a 10% gel and
by autoradiography (see section 2.2.2.4).
4.3.2 Results and discussion
Figure 4-5 shows the gel profile and corresponding
autoradiograph of this experiment. The assay was designed
such that 30 pg membrane protein was loaded onto each lane
of the gel, so that the labelling of proteins in the pellet
and supernatant should equal that in the track for total
labelling. As far as the gel was concerned, there did not
appear to be any difference in the amount of protein loaded
in the tracks showing the profiles of the pellet and
supernatant resulting from the 9,000g and 100,000g spins.
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Fig. 4-5 Release of 32P-ADP-ribosylated proteins from
brush border membranes
A and B show the protein profiles, on a 10%
polyacrylamide gel, and autoradiographic profiles
respectively, when brush border membranes were
incubated with 20 yu.g/ml preactivated cholera toxin
and 5 yuM- [ adenylate-3 2 P ] NAD+ for 20 min at 30°C
as outlined in section 4.3.1. Lane 1 represents
total labelling of proteins; lanes 2 and 4 the
labelling of membrane proteins found in the
pellets resulting from the 9,000g and 100,000g
spins respectively; and lanes 3 and 5 the
labelling of soluble proteins found in the
supernatants also resulting from the 9,000g
and 100,000g spins respectively. The molecular
masses of the proteins, as indicated, are
expressed in kDa.
40 kDa were labelled, but the 37 kDa protein was not. The
protein of 66 kDa which was only labelled in the supernatant
was the bovine serum albumin present in the cholera toxin
activation buffer (see section 2.2.2.2), and which has also
been shown to be ADP-ribosylated by Kun et al. (1976). The
protein was shown to be bovine serum albumin by repeating
the ADP-ribosylation assay in the absence of membranes, and
running the assay mixture on a 10% gel. The gel and
corresponding autoradiograph revealed one band which was
labelled and which had a molecular mass of 66 kDa, the same
as that of bovine serum albumin. The reason for the high
background on the autoradiograph (Fig. 4-5) corresponding to
the supernatant and total labelling tracks on the gel, was
due to the loading of reaction mixtures containing unreacted
32P-NAD+ onto the gel. Both the 45 and 40 kDa proteins
appeared to be present in the supernatant tracks as shown by
the label on the autoradiograph, although this labelling was
quite weak and partially masked by the high background.
Table 4-2 shows the integrated values for the labelling
resulting from the densitometric analysis of the
autoradiograph. The results show that the 9,000g
centrifugation step, used in all of the ADP-ribosylation
assays, was sufficient to pellet all the membrane-bound
proteins. This was shown by the labelling of the 45 and 40
kDa proteins in the pellets, resulting from both the 9,000g
and 100,000g spins, being approximately the same. The small
differences of 6% and 3% observed in the total labelling (a
combination of membrane bound and soluble) of the 45 kDa and
40 kDa proteins respectively, resulting from the 100,000g
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compared to the 9,000g centrifugation, is probably due to
experimental error. Errors in the estimation of the amount
of labelling by densitometric analysis may also have arisen
due to the high background on the autoradiograph. The
experiment was carried out in duplicate and both sets of
data gave very similar results. Thus, it appears that upon
ADP-ribosylation there was approximately a 20% release of
the 40 and 45 kDa membrane-bound proteins into the cytosol.
This means that the o( subunits of G proteins may be released
from the brush border membrane upon ADP-ribosylation by
cholera toxin, allowing them to move freely through the cell
cytosol to the basal-lateral membrane, at the other sid.e of
the cell, where they can interact with the catalytic
subunits of adenylate cyclase, which are said to be located
only on this membrane (see Chapter Five). Since the
subunits of Gs have been found to inhibit adenylate cyclase
activity (Northup et al., 1983b), then it is safe to assume
that the ol subunits must be released from these subunits
so that they, the subunits, can activate adenylate
cyclase. Under the normal hormonal regulation of adenylate
cyclase it is the binding of GTP to Gs that initiates the
activation of the cyclase. It would therefore seem likely
that the GTP binds to the o( subunits (Northup et al., 1982),
causing their release from the subunits and allowing
them to interact with the catalytic subunit. Therefore,
under normal hormonal regulation, the hormone binds its
receptor at the basal-lateral membrane, the receptor binds
Gs and then GTP binds the o( subunit of Gs causing its
release from the subunits. Maybe the released o(
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subxanits remain associated with the basal-lateral membrane
and interact with the catalytic subunits of adenylate
cyclase also on this membrane. It then would be possible
that cholera toxin ADP-ribosylates GTP-bound o( subunits of
cholera-toxin-activatable GTP-binding proteins, and causes
the release of some of these o( subunits from the brush
border membrane so that they can interact with the catalytic
subunit of adenylate cyclase in the basal-lateral membrane.
However, it should be noted that no control experiments were
carried out to determine the amount of release of Gs^i if
any, that occurs in the absence of cholera toxin. Although,
as mentioned earlier it has been found that no ADP-
ribosylation of Gso< occurs in the absence of the toxin
(results not shown), and so any toxin-independent release
would not show up on the autoradiograph. As far as the
radioactive material which is present at the top of the gel
shown in Figure 4-5 is concerned there does not seem to be
any immediate explanation. This would usually be indicative
of aggregated protein, but since the radioactive material is
only present in the soluble fractions (Fig. 4-5B lanes 3 &
5) and not in the pelleted fractions (Fig. 4-5B lanes 2 & 4)
nor in the total labelling track (Fig. 4-5B lane 1) this
cannot be the case here. This view is also supported by the
absence of any aggregated material at the top of the gel
(Fig. 4-5A lanes 3 & 5).
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4.4 Effect of antidiarrhoeal drugs on the ADP-ribosylation
of membrane proteins
4.4.1 Method
5 jjiM- [ adenylate-3 2 P ] NAD+ and 20 jag/ml preactivated cholera
toxin were incubated with 50 jUg membrane protein and various
concentrations (0.1, 0.2, 0.4, 0.7 and 1.0 mM) of the drugs
shown in Figure 4-1, in a reaction volume of 0.1 ml at 30°C
for 30 min, as in section 2.2.2.1. All of the drugs were
freshly prepared for each experiment, as a 5 mM stock
solution, by solubilization in double-distilled water
because they were very light sensitive, and they oxidized on
prolonged exposure to air, acquiring a blue or pink colour.
4.4.2 Results and discussion
From the start of this project it had been decided to look
at the effect of the antidiarrhoeal drugs on the activation
of adenylate cyclase and the phosphorylation of proteins in
the membrane fractions since there seemed to be a good
possibility that they would have an effect on these
processes, as explained earlier in Chapter One (sections
1.4.3 and 1.4.4). Briefly, the movement of ions (Na+-Cl-
absorption and CI- secretion) across the intestinal
epithelium (Kimberg, 1974; Field, 1976) may be mediated by
cyclic AMP (as well as cyclic GMP and Ca2 + ), resulting from
an increase in the activity of adenylate cyclase, and
exerting its effect through the activation of cyclic-AMP-
dependent protein kinase (Alhanaty and Shaltiel, 1979). The
phenothiazine antidiarrhoeal drugs have been found to bind
to calmodulin in a Ca2+-dependent manner, whereas Ca2 * -
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activated calmodulin has been found to activate a number of
Ca2+-dependent enzymes, including adenylate cyclase
(Amiranoff et al., 1983) and protein kinases (Kennedy and
Greengard, 1981). Therefore, it has been proposed that the
drugs bind calmodulin and reduce the activity of both
adenylate cyclase and protein kinase (Levin and Weiss, 1977,
1978; Weiss and Levin, 1978). However, there was no reason
to believe that the drugs would have any effect on the ADP-
ribosylation of membrane proteins, but since the effects on
adenylate cyclase activity and the phosphorylation of
membrane proteins were going to be determined it seemed that
any effects on ADP-ribosylation might as well be also
investigated.
The resulting gel profiles and autoradiographs from the
experiments are shown in Figure 4-6 and the graphs resulting
from the densitometric analysis of the autoradiographs are
shown in Figure 4-7. The effects of the six drugs on each
membrane fraction were investigated separately. This means
that although the labelling in each fraction for a
particular drug cannot be compared, the labelling for each
drug in a particular fraction can be. However, this does
not really matter since the labelling between fractions has
been previously compared (see Fig. 4-3 and Table 4-1).
Figures 4-6 and 4-7 show quite clearly that the drugs do
inhibit the cholera toxin induced ADP-ribosylation of the
45, 40 and 37 kDa membrane proteins.
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Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 jug/ml preactivated cholera
toxin, 5 p.M-[ adenylate-3 2 P] NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 pg membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
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Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 ju.g/ml preactivated cholera
toxin, 5 juM-[adenylate-3 2 P] NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 /ng membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM


















1 2 3 4 5 6 1 2 3 4 5 6
-130-
-131-
Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 jug/ml preactivated cholera
toxin, 5 juM- T adenylate-3 2 P ] NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 )Xg membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0,1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
(lane 5) apd 1.0 mM (lane 6).
B
I (a)-?
:«• , w mm P*5
l£|||
■MteJSi
1 2 3 4 5 6
II (a)
'




















Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 /ug/ml preactivated cholera
toxin, 5 yu.M- [adenylate-3 2 P]NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 yug membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
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Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
jjolyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 /ug/ml preactivated cholera
toxin, 5 juM- [adenylate-3 2 P]NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 jug membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
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Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 jUg/ml preactivated cholera
toxin, 5 yuM- [adenylate-3 2 P]NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 jag membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
(lane 5) and 1.0 mM (lane 6).
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Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 /ug/ml preactivated cholera
toxin, 5 ^uM-[adenylate-32P]NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 pxg membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
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Fig. 4-6 Effect of antidiarrhoeal drugs on the ADP-
ribosylation of membrane proteins
(a) and (b) show the protein profiles (on 10%
polyacrylamide gels) and corresponding
autoradiographs respectively which are produced
when mixed plasma membranes (A), brush border
membranes (B), and basal-lateral membranes (C)
are incubated with 20 ^ug/ml preactivated cholera
toxin, 5 /uM- [adenylate-3 2 P]NAD+ and 0-1 mM drug
for 30 min at 30°C as in section 4.4.1. Each
lane contained 50 jug membrane protein. The drugs
tested were chlorpromazine (I), amitriptyline
(II), trifluoperazine (III), promethazine (IV),
triflupromazine (V) and promazine (VI). The
migration of molecular mass standards expressed
in kDa is as indicated. The concentration of drug
used was as follows; no drug (lane 1), 0.1 mM
(lane 2), 0.2 mM (lane 3), 0.4 mM (lane 4), 0.7 mM
( lane 5) and 1,0 mM (lane 6 ) .
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-7 Effect, of antidiarrhoeal drugs on the incorpor¬
ation of 32P-ADP-ribose into membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
into 40 kDa (Q—□) , 45 kDa («—B) , 37 kDa
(O—<c>> and 66 kDa (A—A)proteins when mixed
plasma membranes (A), brush border membranes (B)
and basal-lateral membranes (C) were incubated
with 20 jug/ml preactivated cholera toxin, 5 ^uM-
[adenylate-32P]NAD+ and 0-1 mM drug for 30 min at
30°C as in section 4.4.1. The drugs used were
chlorpromazine (a), amitriptyline (b), trifluope¬
razine (c), promethazine (d), triflupromazine (e)
and promazine (f). The arbitrary unit of 1 for
mixed plasma membranes, brush border membranes and
basal-lateral membranes corresponds to integrated
values of 30000, 60000 and 15000 respectively,























Fig. 4-7 Effect of antidiarrhoeal drugs on the incorpor¬
ation of 32P-ADP-ribose into membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
into 40 kDa (□ □) , 45 kDa (•—■), 37 kDa
( O—anc* 66 kDa (A—A)proteins when mixed
plasma membranes (A), brush border membranes (B)
and basal-lateral membranes (C) were incubated
with 20 yug/ml preactivated cholera toxin, 5 yUM-
[adenylate-32P]NAD+ and 0-1 mM drug for 30 min at
30°C as in section 4.4.1. The drugs used were
chlorpromazine (a), amitriptyline (b), trifluope¬
razine (c), promethazine (d), triflupromazine (e)
and promazine (f). The arbitrary unit of 1 for
mixed plasma membranes, brush border membranes and
basal-lateral membranes corresponds to integrated
values of 30000, 60000 and 15000 respectively,





























Fig. 4-7 Effect of antidiarrhoeal drugs on the incorpor¬
ation of 32P-ADP-ribose into membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
into 40 kDa (□ O) , 4 5 kDa (■ f|) , 37 kDa
an(i 66 kDa —AJproteins when mixed
plasma membranes (A), brush border membranes (B)
and basal-lateral membranes (C) were incubated
with 20 /U.g/ml preactivated cholera toxin, 5
[adenylate-32P]NAD+ and 0-1 mM drug for 30 min at
30°C as in section 4.4.1. The drugs used were
chlorpromazine (a), amitriptyline (b), trifluope¬
razine (c), promethazine (d), triflupromazine (e)
and promazine (f). The arbitrary unit of 1 for
mixed plasma membranes, brush border membranes and
basal-lateral membranes corresponds to integrated
values of 30000, 60000 and 15000 respectively,








Fig. 4-7 Effect of antidiarrhoeal drugs on the incorpor¬
ation of 3 2 P-ADP-ribose into membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
into 40 kDa ( Q □), 45 kDa (■—M) , 37 kDa
(o-O) and 66 kDa (A—A) proteins when mixed
plasma membranes (A), brush border membranes (B)
and basal-lateral membranes (C) were incubated
with 20 /Xg/ml preactivated cholera toxin, 5 /uM-
[adenylate-32P]NAD+ and 0-1 mM drug for 30 min at
30°C as in section 4.4.1. The drugs used were
chlorpromazine (a), amitriptyline (b), trifluope¬
razine (c), promethazine (d), triflupromazine (e)
and promazine (f). The arbitrary unit of 1 for
mixed plasma membranes, brush border membranes and
basal-lateral membranes corresponds to integrated
values of 30000, 60000 and 15000 respectively,































































Fig. 4-7 Effect of antidiarrhoeal drugs on the incorpor¬
ation of 32P-ADP-ribose into membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
into 40 kDa (□—□), 45 kDa (■—-■), 37 kDa
(O—O) and 66 kDa ( Jk—jtk) proteins when mixed
plasma membranes (A), brush border membranes (B)
and basal-lateral membranes (C) were incubated
with 20 {A.g/ml preactivated cholera toxin, 5 juM-
[adenylate-32P]NAD+ and 0-1 mM drug for 30 min at
30°C as in section 4.4.1. The drugs used were
chlorpromazine (a), amitriptyline (b), trifluope¬
razine (c), promethazine (d), triflupromazine (e)
and promazine (f). The arbitrary unit of 1 for
mixed plasma membranes, brush border membranes and
basal-lateral membranes corresponds to integrated
values of 30000, 60000 and 15000 respectively,































Fig. 4-7 Effect of antidiarrhoeal drugs on the incorpor¬
ation of 32P-ADP-ribose into membrane proteins
Graphs show the incorporation of 32P-ADP-ribose
into 40 kDa (Q—Q), 45 kDa ( ■—®) , 37 kDa
(O O) and 66 kDa (—A)proteins when mixed
plasma membranes (A), brush border membranes (B)
and basal-lateral membranes (C) were incubated
with 20 fxg/ml preactivated cholera toxin, 5 yuJM-
[adenylate-32P]NAD+ and 0-1 mM drug for 30 min at
30°C as in section 4.4.1. The drugs used were
chlorpromazine (a), amitriptyline (b), trifluope¬
razine (c), promethazine (d), triflupromazine (e)
and promazine (f). The arbitrary unit of 1 for
mixed plasma membranes, brush border membranes and
basal-lateral membranes corresponds to integrated
values of 30000, 60000 and 15000 respectively,




Unfortunately, there was a problem with the solubility of
three of the drugs, namely chlorpromazine, trifluoperazine
and triflupromazine. When certain concentrations of the
solubilized drugs were added to the ADP-ribosylation assay
mixture they became insoluble; this was due to a rise in pH
above 6.4 causing the free base to precipitate. The ADP-
ribosylation assay was performed at a pH of 7.5 and no ADP-
ribosylation of membrane proteins was found to occur if the
pH dropped below about 7. The pH of the water-solubilized
drugs was about pH 4-5, but the buffering capacity of the
ADP-ribosylation assay mixture was sufficient to ensure that
when the drug solutions were added to the reaction mixture
the pH did not drop much, if at all, below 7.5. However,
this increase in the pH to 7.5 did cause the precipitation
of the free base and since this pH was necessary for the
ADP-ribosylation to take place, it was an unsolvable
problem. It is also possible that these drugs, at
precipitation of other proteins in the reaction mixture.
Therefore, it is difficult to be certain as to the extent of
insolubility at the higher drug concentrations. Generally,
this solubility became noticeable at final drug concentrat¬
ions of 0.7 and 1 mM, although with trifluoperazine it also
occurred at a concentration of 0.4 mM. This insolubility
has resulted in two effects, one of which was an apparent
increase in protein content, for mainly the proteins of 66
and 40 kDa, on the gels (Fig. 4-6 1(a), 111(a) and V(a) for
mixed plasma (A), brush border (B) and basal-lateral (C)
membranes). The increase in the protein content of these
which
they become less soluble, cause the
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proteins, at concentrations of 0.7 and 1 mM for
chlorpromazine and triflupromazine, and at concentrations of
0.4, 0.7 and 1 mM for trifluoperazine, has resulted in the
second effect, which was an apparent increase in the ADP-
ribosylation of these proteins at these drug concentrations
(Fig. 4-7). This second effect was particularly noticeable
with the drug trifluoperazine (Fig. 4-7B(c) and C(c)), and
this was the drug which seemed to be the most insoluble at
the concentrations mentioned above (Fig. 4-6 III(a) for A, B
and C). These two effects are probably due to the drugs,
originating from the cytosolic fraction S4 (see Fig. 2-1)
having become insoluble, binding to the soluble proteins^and
pelleting them with the membranes when centrifuged at
9,000g. This would then explain the appearance of the 66
kDa protein on the gels at the higher concentrations, which
as discussed in section 4.3.2 is bovine serum albumin. Due
to this insolubility problem it was impossible to say what
the true concentrations of these drugs were in the assay
mixtures, and so it is difficult to make any comparison
between the effects of the drugs on each membrane fraction.
However, apart from this problem there did not seem to be
any consistency in the effect of certain drugs on one
membrane fraction and their effects on one of the other
fractions, even if comparisons are made at the lower drug
concentrations where there appeared to be no insolubility
problem. For example, with mixed plasma membranes the
greatest inhibition of incorporation of 32P-ADP-ribose into
the 40 kDa protein was achieved with chlorpromazine (Fig.
4-7A(a)) and trifluoperazine (Fig. 4-7A(c)) and the worst
inhibition was achieved with promazine (Fig. 4-7A(f)), but
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on the other hand with basal-lateral membranes by far the
largest inhibition was caused by promazine (Fig. 4-7C(f)).
Although, for mixed plasma membranes there does appear to be
a greater initial inhibition of ADP-ribosylation by
chlorpromazine (Fig. 4-7A(a)), trifluoperazine (Fig. 4-7A
(c)) and triflupromazine (Fig. 4-7A(e)), than by
amitriptyline (Fig. 4-7A(b)), promethazine (Fig. 4-7A(d)),
and promazine (Fig. 4-7A(f)). This may also be the case for
brush border membranes (Fig. 4-7B(a)-(f)), but it is not as
obvious as for mixed plasma membranes. Another striking
effect was the much smaller percentage inhibition of the
incorporation of 32P-ADP-ribose on the 40 kDa protein
occuring in brush border membranes (40-50%) (Fig. 4-7B)
compared to mixed plasma membranes (80%) (Fig. 4-7A) and
basal-lateral membranes (80%) (Fig. 4-7C). No immediate
ideas come to mind explaining the reason for this, except
that it may be indicative of there being more than one site
of incorporation of 32P-ADP-ribose on the protein, and that
one of these sites is affected to a much greater extent by
the drugs than the other(s).
It is therefore difficult to draw any conclusions from this
work, particularly as to a relationship between the
inhibition of ADP-ribosylation with the known antidiarrhoeal
and anticalmodulin activities of the drugs. All that can be
stated is that there is obviously some inhibition occuring
and a lot more work needs to be carried out to try and
resolve the many problems that have been found to occur.
Deducing the mechanism by which the drugs inhibit ADP-
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ribosylation is of major importance. Since the drugs are
known to bind calmodulin, does this mean that calmodulin is
also needed for the ADP-ribosyltransferase activity of the
active Ai peptide of cholera toxin? This may be more than a
possibility, but it does seem strange that a bacterium
produces a toxin that is dependent on a molecule of its host
for its activity. Although, the bacteria Bordetella
pertussis and Bacillus anthracis, responsible for the
diseases whooping cough and anthrax respectively, secrete
adenylate cyclase, and adenylate cyclase is known to require
the eukaryotic protein calmodulin for its activity
(Amiranoff et a.Z. , 1983). Also, as mentioned in section
1.4.2, it has been shown that the active Ai peptide of
cholera toxin requires several eukaryotic (Kahn et al.,
1988) ADP-ribosylation factors, which are all GTPases, for
its activity (Tsai et al., 1987, 1988; Price et al., 1988),
and thus is dependent on its host for its activity.
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CHAPTER FIVE
ACTIVATION OF ADENYLATE CYCLASE
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5 . 1 Introduction
As discussed previously in sections 1.6 and 4.1, it has
never been clearly shown how cholera toxin can get to its
substrate in intestinal cells to cause the chain reaction of
events resulting in the characteristic diarrhoea of this
disease. The toxin is produced in the lumen of the gut by
V. cholerae, and enters the cell at the brush border
membrane where it ADP-ribosylates the GTP-activated G
protein causing the release of Gsoi (the oc subunit of the
stimulatory G protein) into the cell cytosol (Chapter Four).
This Gs« must then move through the cytosol until it comes
into contact with, and causes the activation of, the
catalytic component of adenylate cyclase resulting in the
increase in production of cyclic AMP from ATP. This
catalytic component is generally thought to be located only
on the opposite side of the cell from the point of entry of
the toxin, i.e. exclusively in the basal-lateral membrane
(Murer et al., 1976; Walling et al., 1978). Therefore, it
seemed necessary to investigate the cholera toxin activation
of the cyclase in all three membrane fractions (mixed
plasma, brush border and basal-lateral) for the possibility
of a cholera-toxin-activatable adenylate cyclase existing in
the brush border as well as in the basal-lateral membrane.
In another set of experiments, the six antidiarrhoeal drugs
shown in Fig. 4-1 were tested for their ability to inhibit
the cholera-toxin-induced activation of adenylate cyclase.
This was done to try and deduce a relationship between the
inhibition of the cyclase with the anticalmodulin and
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antidiarrhoeal activities of the drugs.
5.2 Activation of adenylate cyclase by cholera toxin
5.2.1 Method
The adenylate cyclase assay measures the activity of the
cyclase by its ability to convert [eg-3 2 P] ATP to cyclic
[32P]AMP. Details of the calculation involved in
determining the amount of cyclic AMP produced per min per
mg protein are shown in Appendix C.
Prior to investigating the time-dependent activation of the
cyclase by both cholera toxin and sodium fluoride, it was
necessary to determine the concentration of toxin required
to achieve the maximal activation of the enzyme, and the
amount of membrane protein needed to get activation. For
determining the concentration of cholera toxin needed,
basically, [<g-32P]ATP and 50 jug ADP-ribosylated membrane
protein were incubated in a reaction volume of 0.1 ml for
20 min at 30°C as outlined in section 2.2.3.1: membrane
proteins were ADP-ribosylated by 0.001-50 |Ag/ml preactivated
cholera toxin as outlined in section 2.2.2.1. This assumed
that the 20 min incubation period and the amount of membrane
protein used for each fraction corresponded to a point on
the linear portion of the respective time course and dose
response curves. For determining the amount of membrane
protein needed, similarly, [cx-32P]ATP and 0-100 jgg ADP-
ribosylated membrane protein were incubated in a reaction
volume of 0.1 ml for 20 min at 30°C as outlined in section
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2.2.3.1: membrane proteins were ADP-ribosylated by 20 j^g/ml
preactivated cholera toxin as outlined in section 2.2.2.1.
This assumed that the 20 min incubation period and the
concentration of the toxin used were suitable conditions for
the assay. To investigate the time-dependent activation of
adenylate cyclase in each membrane fraction by both cholera
toxin and sodium fluoride, It*-3 2 P] ATP and 50 jJtg ADP-
ribosylated membrane protein were incubated in a reaction
volume of 0.1 ml, at 30°C for 0-60 min as outlined in
section 2.2.3.1: membrane proteins were ADP-ribosylated by
20 jug/ml preactivated cholera toxin as outlined in section
2.2.2.1.
5.2.2 Results and discussion
Cholera toxin activated intestinal adenylate cyclase at
concentrations above 0.01 jtg/ml, the maximal effect being at
about 10 jxg/ml (Fig. 5-1). Sodium fluoride activated
maximally at about 10 mM. Therefore, the toxin
concentration of 20 jig/ml used in the assays was found to be
suitable to achieve maximal activation. The membrane
protein dose response curve, shown in Figure 5-2, quite
clearly shows that there was a linear response up to at
least 100 julg protein. Therefore, the 50 jJLg of membrane
protein routinely used in the assay was found to be enough
to achieve good activation of the cyclase.
The results of the time courses for the activation of
adenylate cyclase in mixed plasma, basal-lateral and brush
border membranes by both cholera toxin and sodium fluoride
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log (jLig/ml Cholera Toxin)
Fig. 5-1 Effect of cholera toxin concentration on the
activation of adenylate cyclase.
Mixed plasma membranes (Q—O), basal-lateral
membranes (Jkr—Jk) an(j brush border membranes
were incubated with 0.001-50 jjg/ml
preactivated cholera toxin and [a.-32P]ATP for




Fig. 5-2 Effect of amount of protein on the activation
of adenylate cyclase by cholera toxin
Mixed plasma membranes (Q □ ), basal-lateral
membranes (Jk—Jk) and brush border membranes
( ■—■) were incubated with 20 jU.g/ml preact-
ivated cholera toxin and [c*-32P]ATP for 20 min
at 30°C as in section 5.2.1.
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are shown in Figure 5-3. The graphs show that there was a
greater activation of the cyclase in the basal-lateral
membrane fraction compared to the mixed plasma membrane
fraction for both the toxin and the fluoride, and there was
greater activity in the mixed plasma compared to the brush
border membrane fraction. Table 5-1 shows the specific
activities of the enzyme in the three fractions after
activation by toxin and fluoride: the values were calculated
from the linear portions of the time courses shown in Figure
5-3. The relative specific activities (Table 5-1) show a
2.7- and 2.3-fold increase in adenylate cyclase activity by
cholera toxin and sodium fluoride respectively in basal-
lateral membranes compared to brush border membranes. This
is analagous to the enrichment of (Na+-K* )ATPase in these
fractions (Table 3-2): 2.6-fold greater in basal-lateral
membranes than in brush border membranes. The basal level
of adenylate cyclase activity was found to be very low in
each of the fractions: less than 1 pmol cyclic AMP produced
per min per mg membrane protein. These results imply that
the activation of adenylate cyclase in the brush border
membrane is due to contamination by basal-lateral membranes
and, therefore, the catalytic subunit of the cyclase is
present only in basal-lateral membranes. The graphs (Fig.
5-3) show that the distribution of activities in the three
fractions for the toxin and the fluoride are almost
identical, implying that the two effectors activate the
cyclase either via the same protein or via different
proteins in the same fraction. For this reason, the effect













































5-3 Activation of adenylate cyclase by sodium
fluoride and cholera toxin.
Mixed plasma membranes (Q—Q), basal-lateral
membranes (▲—A.) and brush border membranes
(■—■) were incubated with either (A) 10 mM
sodium fluoride or (B) 20 yUg/ml preactivated
cholera toxin, and [c<-3zP]ATP at 30°C as in
section 5.2.1.
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ADP-ribosylated by cholera toxin was investigated.
5.3 Effect of sodium fluoride on ADP-ribosylated membranes
5.3.1 Method
ADP-ribosylated membranes (mixed plasma, basal-lateral and
brush border) (see section 2.2.2.1) were incubated in a
reaction volume of 0.1 ml, with [ot-3 2 P ] ATP and sodium
fluoride for 20 min at 30°C as outlined in section 2.2.3.1:
membrane proteins were ADP-r ibosylated with 20 jJig/ml
preactivated cholera toxin as outlined in section 2.2.2.1.
The resulting activation of adenylate cyclase was compared
to that produced by membranes treated with either cholera
toxin or sodium fluoride alone. When looking at the effect
of cholera toxin on the activation of adenylate cyclase,
membranes were ADP-ribosylated prior to the adenylate
cyclase assay for 30 min at 30°C, whereas when sodium
fluoride was used as the activator the membranes were
preincubated for 30 min at 30°C. This was to ensure that,
prior to the adenylate cyclase assay, all membranes had been
previously incubated for the same length of time and so the
cyclase would have been subject to the same degree of
inactivation.
5.3.2 Results and discussion
The results of the experiment are shown in Table 5-2. If
sodium fluoride activated the cyclase via a different
regulatory component from that of cholera toxin, then the
amount of cyclic AMP produced would be expected to be the
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additive total produced by each effector on its own, i.e.
for basal-lateral membranes a value of 147 pmol cyclic AMP
produced per minute per mg membrane protein would be
expected. If, on the other hand, sodium fluoride activated
the same protein as cholera toxin, then it is possible that
once Gs<ai has been modified by the toxin it cannot be
activated by fluoride ions, and so the result would be that
only the effect of the toxin would be seen. The results of
the experiment (Table 5-2) appear to agree with this latter
possibility. Therefore, it is quite clear that sodium
fluoride does not increase the specific activity of
adenylate cyclase after the regulatory component, Gsot, has
been modified by cholera-toxin-induced ADP-ribosylation.
This result is consistent with what is generally accepted,
which is that fluoride ions activate adenylate cyclase, as
does cholera toxin, by stimulating the regulatory component,
Gsot . Hence, as well as the regulatory protein being known
as the GTP-binding protein, the hormone-stimulated GTPase,
the N protein (because it binds nucleotides) and the G
protein (because it binds guanine nucleotides), it is also
known as the G/F protein since it confers responsiveness to
both guanine nucleotides and fluoride.
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5.4 Effect of antidiarrhoeal drugs on the activation of
adenylate cyclase by cholera toxin
5.4.1 Method
ADP-ribosylated membranes {mixed plasma, basal-lateral and
brush border) (see section 2.2.2.1) were incubated in a
reaction volume of 0.1 ml, with [c*-32P]ATP and 0-3 mM final
concentration of each of the drugs shown in Figure 4-1, for
20 min at 30°C as outlined in section 2.2.3.1: membrane
proteins were ADP-r ibosylated with 20 Ig/ml preactivated
cholera toxin as outlined in section 2.2.2.1. All drugs
were freshly prepared for each experiment, as a 15 mM stock
solution, by solubilization in double-distilled water
because they were very light sensitive, and they oxidized on
prolonged exposure to air.
5.4.2 Results and discussion
As discussed in sections 1.4.3. and 1.4.4, there was good
reason to believe that the phenothiazines would inhibit
adenylate cyclase activity, since the drugs are known to
bind calmodulin (Prozialeck and Weiss, 1982) and calmodulin
is known to be involved in the activation of adenylate
cyclase (Amiranoff et al., 1983).
The results of the experiments are shown in Figure 5-4. As
in section 4.4, the effects of the six drugs on each
membrane fraction were investigated separately. Therefore,
the quantitative inhibition of cyclic AMP production in each
membrane fraction for a particular drug cannot be compared,




Fig. 5-4 Effect of antidiarrhoeal drugs on the activation
of adenylate cyclase by cholera toxin.
Mixed plasma membranes (A), basal-lateral
membranes (B) and brush border membranes (C) were
incubated with 20 jUg/ml preactivated cholera
toxin, r<a(-32P]ATP and 0-3 mM drug for 20 min at
30°C as in section 5.4.1. The drugs used were
chlorpromazine (A—A.) , ami tr iptyl ine (A A),
trifluoperazine (■ ■), promethazine (Q O) >
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Fig. 5-4 Effect of antidiarrhoeal drugs on the activation
of adenylate cyclase by cholera toxin.
Mixed plasma membranes (A), basal-lateral
membranes (B) and brush border membranes (C) were
incubated with 20 |Ag/ml preactivated cholera
toxin, [o(-32P]ATP and 0-3 mM drug for 20 min at
30°C as in section 5.4.1. The drugs used were
chlorpromazine ( Mk.—▲), amitriptyline (A.—A),
trifluoperazine (■—■ ) , promethazine (□ O) ,
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[DRUG] (mM)
Fig. 5-4 Effect of antidiarrhoeal drugs on the activation
of adenylate cyclase by cholera toxin.
Mixed plasma membranes (A), basal-lateral
membranes (B) and brush border membranes (C) were
incubated with 20 jJig/ml preactivated cholera
toxin, [o(-32P]ATP and 0-3 mM drug for 20 min at
30°C as in section 5.4.1. The drugs used were
chlorpromazine (A A), ami tr iptyl ine (A. A),
trifluoperazine (■ ■) , promethazine (□ □) ,
triflupromazine (A and promazine —"O) .
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quantitative comparisons of the amount of cyclic AMP
produced in each fraction have been previously measured in
section 5.2 (Fig. 5-3 and Table 5-1).
There was a similar problem with the solubility of some of
the drugs at certain concentrations when added to the
adenylate cyclase reaction mixture, as occurred when the
effects of the drugs on ADP-ribosylation were investigated
in section 4.4. The drugs which became insoluble were again
chlorpromazine, trifluoperazine and triflupromazine, but in
this case the drugs appeared to come out of solution at the
slightly higher concentrations of 1 or 1.5 mM and greater.
The drugs probably became insoluble at these higher
concentrations because of a difference in the ionic strength
of this reaction mixture, which is a combination of the ADP-
ribosylation and adenylate cyclase assay reaction mixtures,
with that of the ADP-ribosylation assay reaction mixture
alone described in section 4.4. The insolubility was once
again due to the pH of the reaction mixture being 7.5.
However, as expected the drugs do appear to have continued
inhibiting the cyclase at these concentrations (see Fig.
5-4A, B and C), since not all of the drug can have become
insoluble at these concentrations and pH: the insoluble
precipitate observed was probably a combination of the
insoluble drug and some other component of the reaction
mixture which was also becoming insoluble, as was the case
in section 4.4. Although these drugs appeared to become
insoluble at these higher concentrations, it seems that with
mixed plasma membranes (Fig. 5-4A) maximal inhibition was
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still achieved with chlorpromazine, trifluoperazine and
triflupromazine at these concentrations. With basal-lateral
membranes and brush border membranes maximal inhibition
occured at about 2 mM (Fig. 5-4B) and 2-3 mM (Fig. 5-4C)
respectively. However, unlike the results of the previous
chapter where no firm conclusions could be drawn as to an
effect of the drugs on ADP-ribosylation, this time a trend
could be seen in all three membrane fractions. This trend
was observed in each membrane fraction both at low drug
concentrations, where the drugs were soluble, and high
concentrations, where three of the drugs became insoluble.
There was definitely greater inhibition of cyclase activity
occurring with chlorpromazine, trifluoperazine and
triflupromazine than with the other three drugs (Fig. 5-4A,
B and C). The order for greatest inhibition appears to be
trifluoperazine > chlorpromazine, triflupromazine >
amitripty1ine > promazine > promethazine. This correlates
very well with the known IC50 values (Fig. 4-1) for the
inhibition of calmodulin activity (Prozialeck and Weiss,
1982), as well as with the known antidiarrhoeal activities
of the drugs (Weiss et al . , 1982; Zavecz et al. , 1982);
chlorpromazine, trifluoperazine and triflupromazine have
greater antidiarrhoeal activities than the other drugs.
Therefore, the results of this experiment do show that there
is a relationship between the binding of the drugs to
calmodulin, with their effect on the movement of ions across







The cyclic AMP resulting from the activation of adenylate
cyclase by cholera toxin in the basal-lateral membrane
(Chapter Five), which resulted from the activation of the
o(-subunit of the regulatory component of adenylate cyclase
(Gs ot. ) at the brush border membrane (Chapter Four), exerts
its effect by activating intestinal cyclic-AMP-dependent
protein kinases (Alhanaty and Shaltiel, 1979) at the brush
border membrane. It is thought that the phosphorylation and
dephosj)horylation of brush border membrane proteins is
responsible for controlling the movement of electrolytes
across the small intestinal epithelium (Scalera et al.,
1983); the major secretory response occurs in the brush
border membrane (Frizzell et aI., 1979). The action of
cholera toxin, mediated through cyclic AMP, may result in an
increase in the phosphorylation of certain brush border
membrane proteins and/or may cause the phosphorylation of
unique membrane proteins. This may be responsible for the
decrease in Na+-CI" absorption and increase in Cl~
secretion, which results in the passive movement of water
from the cell, producing the characteristic diarrhoea of the
disease. Indeed, evidence has been provided showing the
activation of a CI- channel by the cyclic-AMP-dependent
phosphorylation of one or more membrane proteins (van
Dommelen and de Jonge, 1984) and a protein of 86 kDa has
been found to be phosphorylated by cyclic AMP in rat
intestinal brush border membranes (de Jonge, 1976; Scalera
et al., 1983). In this study the pattern of phosphorylation
in the brush border, basal-lateral and mixed plasma membrane
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fractions was studied and compared in the presence of the
toxin. The cholera-toxin-induced labelling pattern of brush
border membrane proteins was compared to the pattern
produced in the absence of the toxin to identify any newly
labelled proteins and any increase in the labelling of
proteins that were phosphorylated in the absence of the
toxin.
Unfortunately, due to a lack of time, it was not possible to
investigate the effect of the antipsychotic phenothiazine
drugs (Fig. 4-1) on phosphorylation, but as with adenylate
cyclase (section 5.4), there was good reason to believe that
they would have an effect on the phosphorylation of membrane
proteins. This was because the drugs bind calmodulin in a
Ca2+-dependent manner with high affinity and specificity
(Prozialeck and Weiss, 1982), which would decrease the
binding of the Ca2 *-activated calmodulin to protein kinases,
thus reducing the activity of the kinases as well as the
phosphorylation of proteins, and so alleviating the defect
in the movement of ions across the membrane; the binding of
Ca2'-activated calmodulin activates protein kinases
(Srivastava et al., 1979; Kennedy and Greengard, 1981).
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6.2 The cholera toxin induced phosphorylation of membrane
toxin and 10 ji^M- [^-3 2 P] ATP in a reaction volume of 0.1 ml at
30°C for various times, as outlined in section 2.2.4.
6.2.2 Results and discussion
Initially, brush border membranes were incubated as above
for times of 0-60 min to see what kind of phosphorylation
pattern was obtained. The resulting autoradiographic
profile (Fig. 6-1) showed one major labelled band,
corresponding to a molecular mass of 53 kDa on the 10%
polyacrylamide gel. The incorporation of label on this
protein increased up to about 2 min; after this time the
protein was dephosphorylated, and by about 20 min hardly any
labelling was observed. There were other weaker labelled
bands corresponding to molecular masses of 45 and 42 kDa
(Fig. 6-1), and the labelling of these proteins also reached
a maximum at about 2 min. However, the proteins ran much
faster than usual for a 10% polyacrylamide gel, and so some
of the lower molecular mass proteins might have either run
with the dye front or have run off the gel completely.
Since there was obviously something wrong with the gel it
could not be determined whether or not there were any lower
molecular mass proteins that were labelled. Therefore,
fresh solutions for making the gels were made and the
experiment was repeated both in the presence and absence of
cholera toxin for times of 20 s to 10 min. This would show
proteins
6.2.1 Method




Fig. 6-1 Incorporation of 32P-phosphate into brush border
membrane proteins
Brush border membranes were incubated with
20 jUg/ml preactivated cholera toxin and 10 jlM-
[y-3 2 P]ATP for times of 0 min (lane 1), 20 s
(lane 2), 40 s (lane 3), 1 min (lane 4), 2 min
(lane 5), 5 min (lane 6), 10 min (lane 7), 20 min
(lane 8), 40 min (lane 9) and 60 min (lane 10) at
30 °C. Membranes (50 jig membrane protein per lane)
were run on a 10% polyacrylamide gel and the
resulting autoradiograph is shown above.
Migration of molecular mass standards expressed
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any difference in labelling as a result of adding the toxin.
The results of the experiment (Fig. 6-2) show that as well
as the 53, 45 and 42 kDa proteins, two other proteins were
also labelled; one of 36 kDa, which was phosphorylated after
an incubation time of about 5 min, and one of 30 kDa, which
was very weakly labelled and was phosphorylated after an
incubation time of about 2 min. Interestingly, in the
absence of cholera toxin only two proteins appeared to be
labelled. These were the ones of 53 and 42 kDa, and both
were phosphorylated to a much smaller extent than in the
presence of the toxin. It is possible that the proteins of
45 and 30 kDa were also phosphorylated, but did not show up
on the autoradiograph because they were only weakly labelled
in comparison to the proteins of 53 and 42 kDa, as was the
case in the presence of the toxin. However, the protein of
36 kDa was definitely not phosphorylated in the absence of
the toxin, since in the presence of toxin it was labelled to
a much greater extent than the 42 kDa protein and yet the
labelling of this 42 kDa protein showed up in the absence of
toxin.
The next stage was to look at the phosphorylation of
proteins in the mixed plasma and basal-lateral membrane
fractions (Fig. 6-3) and compare the patterns obtained to
that which was found for brush border membranes (Fig. 6-1
and Fig. 6-2). Figure 6-3 shows that essentially no
labelling of basal-lateral membrane proteins was obtained
(Fig. 6-3B), except a faint band corresponding to the 53 kDa
protein; however there was labelling of the 53, 42 and 36
-183-
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Fig. 6-2 Effect of cholera toxin on the phosphorylation
of brush border membrane proteins
Brush border membranes were incubated with 10 ytM-
[y-32 P]ATP in both the presence (A) and absence
(B) of 20 jmg/ml preactivated cholera toxin for
times of 20 s (lane 1), 40 s (lane 2), 1 min
(lane 3), 2 min (lane 4), 5 min (lane 5) and
10 min (lane 6) at 30°C. Membranes (50 yug
membrane protein per lane) were run on a 10%
polyacrylamide gel and the resulting
autoradiograph is shown above. Migration of







Fig. 6-3 Phosphorylation of membrane proteins
Mixed plasma membranes (A), basal-lateral
membranes (B) and brush border membranes (C) were
incubated with 10 yaM- [2 P] ATP and 20 fAg/ml
preactivated cholera toxin for times of 0 min
(lane 1), 30 s (lane 2), 1 min (lane 3), 2 min
(lane 4), 5 min (lane 5) and 10 min (lane 6) at
30 °C. Membranes (50 fxg membrane protein per lane)
were run on a 10% polyacrylamide gel and the
resulting autoradiograph is shown above.
Migration of molecular mass standards expressed in
kDa is as indicated.
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kDa proteins in the mixed plasma membrane fraction
(Fig. 6-3A), although this was also very weak. Therefore,
there appear to be two brush border membrane proteins, with
molecular masses of 53 and 42 kDa, whose labelling was
increased in the presence of cholera toxin, and certainly
one uniquely labelled protein of 36 kDa and maybe two of 45
and 30 kDa which were labelled only in the presence of the
toxin. There was no labelling of a 86 kDa protein as was
found with rat intestinal brush border membranes by de Jonge
(1976) and Scalera et al. (1983). As previously mentioned,
the phosphorylation of proteins in the basal-lateral
membrane fraction was virtually nonexistent, but the faint
labelling observed of the 53 kDa protein was probably due to
crosscontamination of the fraction with brush border
membranes as discussed in section 3.3.5. The assay
conditions need to be optimized further to try and increase
the labelling of the minor phosphorylated proteins or maybe
to achieve the phosphorylation of new proteins. Oddly,
since cholera toxin action results in a decrease in Na+-Cl-
absorption and an increase in CI- secretion, and since the
phosphorylation of brush border membrane proteins is thought
to be responsible for these changes in ion movement, then
because a continual loss of water is observed in the
disease, any cholera-toxin-induced phosphorylation would be
expected to be permanent. This, as shown in Figure 6-2, is
certainly not the case, as was also found by Scalera et al.
(1983). They observed that the in vivo incorporation of 3 2 P
into brush border membrane proteins increased up to 60 min
and remained constant afterwards, but state that in vitro
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phosphorylation for times greater than 20 s led to
considerable dephosphorylation reactions. Under the
experimental conditions adopted in this study this
dephosphorylation cannot be due to the level of cyclic AMP
being reduced due to a depletion in NAD+ content. It is
more likely to be due to differences in the structure and
organization of the membranes of in vivo and in vitro
systems, affecting protein kinases and 32P-acceptor sites as
suggested by Scalera et al . (1983).
In conclusion, although the assay appears to be working, it
is possible that the phosphorylation seen is not of any
particular physiological interest or at least is not the
phosphorylation responsible for controlling the ion
transport changes occuring at the brush border membrane.
However, it is clear that there are some interesting cholera
toxin effects at the brush border membrane and that more
work needs to be done on this phosphorylation assay,







The main purpose of this study was to investigate the
mechanisms by which cholera toxin causes the massive
secretion of fluid from intestinal cells, as well as to look
at the effects of antidiarrhoeal drugs on these processes.
Although a lot is known about the events leading to the
water loss, most of the work has been done using cell types
not involved with the pathology of the disease (Gill and
Meren, 1978; Cassel and Pfeuffer, 1978; Northup et al.,
1980; Becker and Blecher, 1981; Raufman and Cosowsky, 1987),
and so it seemed necessary to look specifically at effects
on intestinal epithelial cells. It is hoped that eventually
the results obtained from studying these mechanisms will
help in improving the rational design of antidiarrhoeal
drugs, and ultimately improve prophylaxis or the treatment
of cholera and other diarrhoeal disease.
Initially, a mixed plasma membrane preparation, consisting
of brush border and basal-lateral membranes, was prepared by
differential centrifugation from rabbit intestinal
epithelial cell scrapings. The brush border and basal-
lateral membranes were separated by MgCl2 precipitation and
the purification assessed by marker enzyme assays.
Three proteins of 45, 40 and 37 kDa were found to be ADP-
ribosylated by cholera toxin in brush border membranes, and
possibly to a much smaller degree in basal-lateral
membranes; the vast majority of the ADP-ribosylation
observed in the basal-lateral membrane fraction was due to
crosscontamination with brush border membranes, as judged by
marker enzyme assay results. The 45 kDa protein has the
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same molecular mass as the oi subunit of the regulatory
component of other adenylate cyclases, but the 40 kDa
protein which was the major ADP-ribosylated protein may be
Gsot since the molecular mass of Gs« has not been determined
for intestinal cells. The identity of Gs<* should be
determined by immunological means initially, and then by
amino acid sequencing. Any relationship between the 45, 40
and 37 kDa proteins should be investigated by purifing the
proteins by running them in a second dimension (eg
isoelectric focussing). They could then be digested with
proteolytic enzymes, to look for any similarities between
them, and they could also be at least partially sequenced.
Determination of their amino acid sequences would also aid
in their identification, since they could then be compared
with other published protein sequences, including components
of the adenylate cyclase complex that have been purified in
other cells, which are stored in data-bases. The 37 kDa
protein is unusual in that it does not seem to have been
reported in the literature as a protein that is ADP-
ribosylated. This protein, though, does have a molecular
mass similar to that of the subunit of Gs (35 kDa) (for
example see Neer and Clapham, 1988), and so its amino acid
sequence should be also compared to known £ subunit
sequences, even though the ^ subunit has not been reported
to be ADP-ribosylated. Evidence was also provided showing
that about 20% of the 45 and 40 kDa proteins are released
from the brush border membrane upon ADP-ribosylation.
Further experiments should be carried out to see if this
release increases with time, ensuring that there is
sufficient [adenylate-32P]NAD+ in the reaction mixture.
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Cholera toxin and sodium fluoride were both found to
activate adenylate cyclase via the same regulatory component
(Gs ) , but only in basal-lateral membranes: any activation
observed in the brush border membrane fraction was due to
crosscontamination with basal-lateral membranes, as judged
by marker enzyme assay results. The release of the Gs«*-like
protein from the brush border membrane, where it is only to
be found, explains how it can can get to the catalytic
subunit of adenylate cyclase, located only in the basal-
lateral membrane, to cause an increase in the production of
cyclic AMP.
This increase in cyclic AMP, resulting from the activation
of adenylate cyclase, caused an increase in the
phosphorylation of two proteins of 53 and 42 kDa, and the
unique phosphorylation of a 36 kDa protein and maybe two of
45 and 30 kDa, all in the brush border membrane. Further
studies on the phosphorylation of proteins need to be done,
to see if by altering conditions any new proteins can be
labelled or to see if the labelling of existing proteins can
be increased. Whether or not any of the above labelled
proteins are physiologically relevant awaits further
studies.
The results of this study agree with the following theory
for the mechanism of action of cholera toxin. The active Ai
peptide of cholera toxin catalyzes the ADP-ribosylation of
the o(, subunit of the stimulatory regulatory component of
adenylate cyclase, which is located only in the brush border
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membrane. This ADP-ribosylation causes the release of the
c£ subunit from the membrane, which then moves through the
cell cytosol to the basal-lateral membrane where it
activates the catalytic component of adenylate cyclase. The
resulting increase in the cyclic AMP content of the cell
activates cyclic-AMP-dependent protein kinases causing the
phosphorylation of brush border membrane proteins. This
phosphorylation is thought to mediate the movement of ions
across the membrane; specifically it is thought to cause a
decrease in Na+-CI- absorption in villus cells (Fan and
Powell, 1983) and an increase in Cl~ secretion in crypt
cells (van Dommelen and de Jonge, 1984).
One of the main things that still needs to be done is to
investigate the effect of cholera toxin on ion transport.
This would involve measuring the uptake of sodium and
chloride into vesicles prepared from the membranes using
radioactive markers. This procedure (for example see van
Dommelen and de Jonge, 1984) is accepted as a reasonable
working model of the intact epithelium, and would provide a
useful tool for looking at how biochemical changes might
affect secretion. A correlation between ADP-ribosylation
and/or adenylate cyclase activity and variations in
secretion, in vesicles made from both fractions of the
purified membrane and in intact cells, could then be
investigated. It could be determined whether the
reappearance of phosphorylated protein bands coincided with
changes in ion secretion. If such bands existed then they
could be possibly identified by comparing them with those
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that have already been shown in published papers (for
example see de Jonge and Lohmann, 1985). The proteins could
also be analyzed by digestion, sequenced and the sequences
compared to those in data-bases as before. It should be
remembered that it is not absolutely proved, even if always
assumed, that the fluid loss is actually affected by
adenylate cyclase at all: some workers favour guanylate
cyclase to be responsible for the changes in ion transport
at the brush border membrane (de Jonge, 1976; Scalera et
al., 1983). The changes in the movement of ions may also be
due to a calcium effect (Bolton and Field, 1977) resulting
from an activation of the phosphatidyl inositol lipid
signalling pathway.
As far as the drug aspect of the project was concerned, all
of the six drugs tested were found to inhibit both the ADP-
ribosylation of proteins and the activation of adenylate
cyclase. Specifically, the drugs inhibited adenylate
cyclase activity to the greatest extent in the order
trifluoperazine > chlorpromazine, triflupromazine >
amitriptyline > promazine > promethazine. This correlates
very well with the published antidiarrhoeal activities of
the drugs (Weiss et al., 1982; Zavecz et al . , 1982), as well
as with the published IC50 values for the inhibition of
calmodulin activity (Prozialeck and Weiss, 1982), i.e.
trifluoperazine, chlorpromazine and triflupromazine have
greater antidiarrhoeal activity and lower IC50 values than
the other three drugs. This also seems to be the case for
the inhibition of ADP-ribosylation, but is not as obvious.
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These results are obviously only preliminary and further
work needs to be done, particularly because of the drug
solubility problem, but they do show that the antipsychotic
phenothiazines do inhibit ADP-ribosylation and adenylate
cyclase activity.
Unfortunately, the effects of the drugs on phosphorylation
were not investigated because the phosphorylation assay
itself has not yet been fully characterized. However, it
should be stated that the phosphorylation assay cannot be
used as it stands when looking at the effect of the drugs on
phosphorylation. The assay was designed so that the ADP-
ribosylation of Gs and the increase in production of cyclic
AMP would occur simultaneously, to ensure that as soon as
the cyclic AMP was produced it would activate protein kinase
and cause the phosphorylation of membrane proteins. This
means that the effects of drugs on the phosphorylation
pattern would be difficult to interpret, since it would be
impossible to tell whether any reduction in the
phosphorylation of proteins was due to the inhibition of
protein kinase activity, or whether it was due to the
inhibition of adenylate cyclase activity as well as the
inhibition of ADP-ribosylation. The problem with separating
the phosphorylation assay from the adenylate cyclase assay
and the ADP-ribosylation assay, is that unlabelled ATP would
have to be added to the adenylate cyclase assay to produce
cyclic AMP, and so when the adenylate cyclase reaction
mixture is added to the phosphorylation assay mixture
containing [^-32P]ATP there would be no incorporation of
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label, since the proteins would have been already
phosphorylated with the unlabelled ATP. The problem,
therefore, lies in the fact that both adenylate cyclase and
protein kinase require ATP for producing cyclic AMP and
phosphorylating proteins respectively, and because protein
kinase requires the cyclic AMP produced by adenylate cyclase
for its activity, thus making it impossible to separate the
two processes so that the phosphorylation can be studied
independently. The answer may be that the assays need not
be separated at all, it may be simply a question of there
being a difference in the times taken to inhibit the
different processes, particularly since phosphorylation
occurs so rapidly: the time taken to inhibit ADP-
ribosylation and adenylate cyclase activity for a particular
drug concentration may not be as fast as the time taken to
inhibit protein kinase activity. However, once the effects
of the drugs on the phosphorylation of membrane proteins are
known, their effects on ion flux should be studied in vitro
and, if possible, in vivo to see if the drugs inhibit the
secretory and/or the antiabsorptive effects of the toxin.
If the drugs inhibit the cholera-toxin-induced
phosphorylation of different proteins, and also inhibit
different ion transport processes, then the results may give
some clues as to the function of the proteins.
Finally, changes in the calcium and calmodulin
concentrations should be looked at more directly, and other
second messenger systems, such as cyclic GMP and inositol
phosphate and its derivatives, should be investigated.
-197-
The results presented in this report have gone someway in
helping to understand the mechanisms by which cholera toxin
causes the disease cholera, but as indicated in this chapter
there are still many things that need to done before any
advances can be made in developing more effective drugs.
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APPENDIX A The primary structure of cholera toxin B subunit
The complete amino acid sequence of the B subunit was
determined from the nucleotide sequence of the single ctx
operon copy of strain 2125 (El Tor biotype) (Mekalanos et
























APPENDIX B The primary structure of cholera toxin A subunit
The complete amino acid sequence of the A subunit was
determined from the nucleotide sequence of the single ctx
operon copy of strain 2125 (El Tor biotype) (Mekalanos et
al . , 1983). The A subunit is cleaved either at position 1
or at position 2 (with the loss of two serine residues)
producing the peptides Ai (1-193) and A2 (194-240). The




















































APPENDIX C Adenylate cyclase assay: calculation of results
[based on the method of Salomon (1979)]
A = ATP (pmol per assay tube)
E = enzyme (jag membrane protein per assay tube)
Primed letters = 32P channel in scintillation counter
Unprimed letters = 3H channel in scintillation counter
H, H/ = cpm standard cyclic [8-3H]AMP
P, P/ = cpm standard [«,-32P]ATP
S, S/ = cpm sample
All values have the background value subtracted
The specific radioactivity of [o(-32P]ATP (in cpm/pmol) with
a 1:100 dilution is
Rs P = P/ x 100
A
The correction for 3H counts in the 32P channel is
F = H/ x S
H
The amount of membrane protein per assay is E mg
1000
The recovery from the columns is S x 100%
H
Therefore, the gross amount of cyclic AMP produced in each
assay tube (in pmol/mg protein for time t) is
cyclic AMPgross = H x (S/ - F) x 1000
S Rs p x E
The blank value (Z) is calculated similarly, and the net
amount of cyclic AMP produced (in pmol/mg protein for time
t) is obtained by subtracting Z from the gross value:
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